In the last 12 months, insiders at HCA Healthcare, Inc. ($HCA) filed 577 transactions with the SEC: 13 open-market purchases totaling $88,208 and 79 sales totaling $97,215,457. Net insider sentiment: net selling.
HCA Healthcare, Inc. operates in the Services-general medical & surgical hospitals, nec industry (Industrial Applications and Services sector).
Most Active Insiders
- Elcan Patricia F (TenPercentOwner) — 6 transactions totaling $738,429,720
- HAZEN SAMUEL N (CEO) — 45 transactions totaling $110,336,733
- Foster Jon M (EVP and COO) — 48 transactions totaling $76,121,927
- Cuffe Michael S. (EVP and Chief Clinical Officer) — 37 transactions totaling $47,229,730
- RUTHERFORD BILL B (CFO and EVP) — 28 transactions totaling $32,515,227
View all SEC Filings for HCA Healthcare, Inc. (HCA).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 13, 2026 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | M | Common Stock | 5000 | $236.61 | 15,990.0000 | 239,495,000 | 45.50% | 0.00% |
| Feb. 13, 2026 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | F | Common Stock | 3306 | $540.29 | 12,684.0000 | 239,495,000 | 20.68% | 0.00% |
| Feb. 18, 2026 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | S | Common Stock | 1694 | $533.37 | 10,990.0000 | 239,495,000 | 13.36% | 0.00% |
| Feb. 13, 2026 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | M | Stock Appreciation Right | 5000 | $0.00 | 8,860.0000 | 239,495,000 | 36.08% | 0.00% |
| Feb. 10, 2026 | Berres Jennifer | SVP & Chief Human Res. Officer | F | Common Stock | 2515 | $502.05 | 20,013.0000 | 239,495,000 | 11.16% | 0.00% |
| Feb. 10, 2026 | Berres Jennifer | SVP & Chief Human Res. Officer | A | Common Stock | 7116 | $0.00 | 22,528.0000 | 239,495,000 | 46.17% | 0.00% |
| Feb. 10, 2026 | Cuffe Michael S. | EVP and Chief Clinical Officer | F | Common Stock | 3501 | $502.05 | 32,079.9017 | 239,495,000 | 9.84% | 0.00% |
| Feb. 10, 2026 | Cuffe Michael S. | EVP and Chief Clinical Officer | A | Common Stock | 9628 | $0.00 | 35,580.9017 | 239,495,000 | 37.10% | 0.00% |
| Feb. 10, 2026 | Foster Jon M | EVP and COO | F | Common Stock | 5888 | $502.05 | 194,516.0000 | 239,495,000 | 2.94% | 0.00% |
| Feb. 10, 2026 | Foster Jon M | EVP and COO | A | Common Stock | 15696 | $0.00 | 200,404.0000 | 239,495,000 | 8.50% | 0.01% |
| Feb. 10, 2026 | HAZEN SAMUEL N | CEO | F | Common Stock | 21323 | $502.05 | 1,382,294.0000 | 239,495,000 | 1.52% | 0.01% |
| Feb. 10, 2026 | HAZEN SAMUEL N | CEO | A | Common Stock | 54934 | $0.00 | 1,403,617.0000 | 239,495,000 | 4.07% | 0.02% |
| Feb. 10, 2026 | Marks Mike A | EVP and CFO | F | Common Stock | 1690 | $502.05 | 73,076.0000 | 239,495,000 | 2.26% | 0.00% |
| Feb. 10, 2026 | Marks Mike A | EVP and CFO | A | Common Stock | 5026 | $0.00 | 74,766.0000 | 239,495,000 | 7.21% | 0.00% |
| Feb. 10, 2026 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | F | Common Stock | 3006 | $502.05 | 10,990.0000 | 239,495,000 | 21.48% | 0.00% |
| Feb. 10, 2026 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | A | Common Stock | 8372 | $0.00 | 13,996.0000 | 239,495,000 | 148.86% | 0.00% |
| Feb. 10, 2026 | Rossitto Erica | SVP & Chief Nurse Executive | F | Common Stock | 418 | $502.05 | 10,407.0000 | 239,495,000 | 3.86% | 0.00% |
| Feb. 10, 2026 | Rossitto Erica | SVP & Chief Nurse Executive | A | Common Stock | 1676 | $0.00 | 10,825.0000 | 239,495,000 | 18.32% | 0.00% |
| Feb. 10, 2026 | Wyatt Christopher F. | SVP & Controller | F | Common Stock | 1034 | $502.05 | 48,379.0000 | 239,495,000 | 2.09% | 0.00% |
| Feb. 11, 2026 | Wyatt Christopher F. | SVP & Controller | S | Common Stock | 4000 | $505.00 | 44,379.0000 | 239,495,000 | 8.27% | 0.00% |
| Feb. 10, 2026 | Wyatt Christopher F. | SVP & Controller | A | Common Stock | 3350 | $0.00 | 49,413.0000 | 239,495,000 | 7.27% | 0.00% |
| Feb. 11, 2026 | Berres Jennifer | SVP & Chief Human Res. Officer | S | Common Stock | 4010 | $526.16 | 11,993.0000 | 239,495,000 | 25.06% | 0.00% |
| Feb. 11, 2026 | Berres Jennifer | SVP & Chief Human Res. Officer | S | Common Stock | 4010 | $503.00 | 16,003.0000 | 239,495,000 | 20.04% | 0.00% |
| Feb. 6, 2026 | FRIST THOMAS F III | Not found | J | Common Stock, par value $0.01 per share | 36557141 | $0.00 | 68,854,847.0000 | 239,495,000 | 113.19% | 15.26% |
| Feb. 6, 2026 | Frisco Holding II | Not found | J | Common Stock, par value $0.01 per share | 36557141 | $0.00 | 36,557,141.0000 | 239,495,000 | 9999.99% | 15.26% |
| Feb. 6, 2026 | Frisco Holding II | Not found | J | Common Stock, par value $0.01 per share | 36629188 | $0.00 | 0.0000 | 239,495,000 | 100.00% | 15.29% |
| Feb. 6, 2026 | HERCULES HOLDING II | Not found | J | Common Stock, par value $0.01 per share | 36629188 | $0.00 | 32,282,889.0000 | 239,495,000 | 53.15% | 15.29% |
| Feb. 6, 2026 | Elcan Patricia F | Not found | J | Common Stock, par value $0.01 per share | 36557141 | $0.00 | 69,033,374.0000 | 239,495,000 | 112.57% | 15.26% |
| Feb. 6, 2026 | FRIST THOMAS F JR | Not found | J | Common Stock, par value $0.01 per share | 36629188 | $0.00 | 32,761,844.0000 | 239,495,000 | 52.79% | 15.29% |
| Feb. 6, 2026 | FRIST THOMAS F JR | Not found | J | Common Stock, par value $0.01 per share | 36557141 | $0.00 | 69,318,985.0000 | 239,495,000 | 111.58% | 15.26% |
| Feb. 6, 2026 | Frist William R | Not found | J | Common Stock, par value $0.01 per share | 36629188 | $0.00 | 32,698,766.0000 | 239,495,000 | 52.83% | 15.29% |
| Feb. 6, 2026 | Frist William R | Not found | J | Common Stock, par value $0.01 per share | 36557141 | $0.00 | 69,255,907.0000 | 239,495,000 | 111.80% | 15.26% |
| Feb. 6, 2026 | FRIST THOMAS F III | Not found | J | Common Stock, par value $0.01 per share | 36629188 | $0.00 | 32,297,706.0000 | 239,495,000 | 53.14% | 15.29% |
| Feb. 6, 2026 | Elcan Patricia F | Not found | J | Common Stock, par value $0.01 per share | 36629188 | $0.00 | 32,476,233.0000 | 239,495,000 | 53.00% | 15.29% |
| Feb. 5, 2026 | Wyatt Christopher F. | SVP & Controller | F | Common Stock | 5674 | $513.76 | 46,063.0000 | 239,495,000 | 10.97% | 0.00% |
| Feb. 5, 2026 | Foster Jon M | EVP and COO | M | Stock Appreciation Right | 29330 | $0.00 | 0.0000 | 239,495,000 | 100.00% | 0.01% |
| Feb. 5, 2026 | Foster Jon M | EVP and COO | F | Common Stock | 16076 | $513.76 | 184,708.0000 | 239,495,000 | 8.01% | 0.01% |
| Feb. 5, 2026 | Foster Jon M | EVP and COO | M | Common Stock | 29330 | $139.06 | 200,784.0000 | 239,495,000 | 17.11% | 0.01% |
| Feb. 5, 2026 | Wyatt Christopher F. | SVP & Controller | M | Stock Appreciation Right | 10670 | $0.00 | 0.0000 | 239,495,000 | 100.00% | 0.00% |
| Feb. 5, 2026 | Wyatt Christopher F. | SVP & Controller | M | Common Stock | 10670 | $139.06 | 51,737.0000 | 239,495,000 | 25.98% | 0.00% |
| Feb. 4, 2026 | HAZEN SAMUEL N | CEO | J | Common Stock | 1045 | $498.35 | 1,348,683.0000 | 239,495,000 | 0.08% | 0.00% |
| Feb. 4, 2026 | HAZEN SAMUEL N | CEO | J | Common Stock | 1045 | $498.35 | 1,348,683.0000 | 239,495,000 | 0.08% | 0.00% |
| Feb. 3, 2026 | HAZEN SAMUEL N | CEO | S | Common Stock | 120 | $497.18 | 1,349,728.0000 | 239,495,000 | 0.01% | 0.00% |
| Feb. 3, 2026 | HAZEN SAMUEL N | CEO | S | Common Stock | 4293 | $498.12 | 1,349,848.0000 | 239,495,000 | 0.32% | 0.00% |
| Feb. 3, 2026 | HAZEN SAMUEL N | CEO | S | Common Stock | 5162 | $498.80 | 1,354,141.0000 | 239,495,000 | 0.38% | 0.00% |
| Feb. 3, 2026 | HAZEN SAMUEL N | CEO | S | Common Stock | 7395 | $500.69 | 1,365,492.0000 | 239,495,000 | 0.54% | 0.00% |
| Feb. 3, 2026 | HAZEN SAMUEL N | CEO | S | Common Stock | 14716 | $502.95 | 1,377,889.0000 | 239,495,000 | 1.06% | 0.01% |
| Feb. 3, 2026 | HAZEN SAMUEL N | CEO | S | Common Stock | 5002 | $502.15 | 1,372,887.0000 | 239,495,000 | 0.36% | 0.00% |
| Feb. 3, 2026 | HAZEN SAMUEL N | CEO | S | Common Stock | 6189 | $500.02 | 1,359,303.0000 | 239,495,000 | 0.45% | 0.00% |
| Feb. 3, 2026 | Cuffe Michael S. | EVP and Chief Clinical Officer | G | Common Stock | 4050 | $0.00 | 25,952.9017 | 239,495,000 | 13.50% | 0.00% |
| Feb. 3, 2026 | Cuffe Michael S. | EVP and Chief Clinical Officer | S | Common Stock | 1500 | $498.09 | 30,002.9017 | 239,495,000 | 4.76% | 0.00% |
| Jan. 30, 2026 | HAZEN SAMUEL N | CEO | F | Common Stock | 41483 | $488.27 | 1,391,560.0000 | 239,495,000 | 2.89% | 0.02% |
| Jan. 30, 2026 | HAZEN SAMUEL N | CEO | M | Stock Appreciation Right | 84360 | $0.00 | 0.0000 | 239,495,000 | 100.00% | 0.04% |
| Jan. 29, 2026 | Foster Jon M | EVP and COO | A | Stock Appreciation Right | 11945 | $0.00 | 11,945.0000 | 239,495,000 | 9999.99% | 0.00% |
| Jan. 29, 2026 | Berres Jennifer | SVP & Chief Human Res. Officer | A | Stock Appreciation Right | 6206 | $0.00 | 6,206.0000 | 239,495,000 | 9999.99% | 0.00% |
| Jan. 29, 2026 | Cuffe Michael S. | EVP and Chief Clinical Officer | A | Stock Appreciation Right | 8067 | $0.00 | 8,067.0000 | 239,495,000 | 9999.99% | 0.00% |
| Jan. 29, 2026 | HAZEN SAMUEL N | CEO | A | Stock Appreciation Right | 55846 | $0.00 | 55,846.0000 | 239,495,000 | 9999.99% | 0.02% |
| Jan. 29, 2026 | Wyatt Christopher F. | SVP & Controller | A | Stock Appreciation Right | 2560 | $0.00 | 2,560.0000 | 239,495,000 | 9999.99% | 0.00% |
| Jan. 29, 2026 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | A | Stock Appreciation Right | 8067 | $0.00 | 8,067.0000 | 239,495,000 | 9999.99% | 0.00% |
| Jan. 29, 2026 | Marks Mike A | EVP and CFO | A | Stock Appreciation Right | 11945 | $0.00 | 11,945.0000 | 239,495,000 | 9999.99% | 0.00% |
| Jan. 30, 2026 | HAZEN SAMUEL N | CEO | M | Common Stock | 84360 | $81.96 | 1,433,043.0000 | 239,495,000 | 6.25% | 0.04% |
| Nov. 14, 2025 | HAZEN SAMUEL N | CEO | G | Common Stock | 14830 | $0.00 | 1,348,683.0000 | 242,459,000 | 1.09% | 0.01% |
| Nov. 3, 2025 | Marks Mike A | EVP and CFO | G | Common Stock | 165 | $0.00 | 69,905.0000 | 242,459,000 | 0.24% | 0.00% |
| Nov. 5, 2025 | Marks Mike A | EVP and CFO | G | Common Stock | 165 | $0.00 | 69,740.0000 | 242,459,000 | 0.24% | 0.00% |
| Nov. 3, 2025 | Marks Mike A | EVP and CFO | G | Common Stock | 165 | $0.00 | 69,740.0000 | 242,459,000 | 0.24% | 0.00% |
| Nov. 3, 2025 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | M | Stock Appreciation Right | 13170 | $0.00 | 0.0000 | 242,459,000 | 100.00% | 0.01% |
| Nov. 5, 2025 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | S | Common Stock | 3892 | $473.79 | 5,624.0000 | 242,459,000 | 40.90% | 0.00% |
| Nov. 3, 2025 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | F | Common Stock | 9278 | $461.56 | 9,516.0000 | 242,459,000 | 49.37% | 0.00% |
| Nov. 3, 2025 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | M | Common Stock | 13170 | $236.61 | 18,794.0000 | 242,459,000 | 234.18% | 0.01% |
| Oct. 31, 2025 | HAZEN SAMUEL N | CEO | F | Common Stock | 28173 | $459.68 | 1,363,513.0000 | 242,459,000 | 2.02% | 0.01% |
| Oct. 31, 2025 | HAZEN SAMUEL N | CEO | M | Stock Appreciation Right | 58050 | $0.00 | 0.0000 | 242,459,000 | 100.00% | 0.02% |
| Oct. 31, 2025 | HAZEN SAMUEL N | CEO | M | Common Stock | 58050 | $69.58 | 1,391,686.0000 | 242,459,000 | 4.35% | 0.02% |
| Sept. 8, 2025 | Cuffe Michael S. | EVP and Chief Clinical Officer | S | Common Stock | 3836 | $418.84 | 31,502.9017 | 261,805,999 | 10.85% | 0.00% |
| Sept. 4, 2025 | Cuffe Michael S. | EVP and Chief Clinical Officer | M | Stock Appreciation Right | 10920 | $0.00 | 10,000.0000 | 261,805,999 | 52.20% | 0.00% |
| Sept. 4, 2025 | Cuffe Michael S. | EVP and Chief Clinical Officer | M | Common Stock | 10920 | $173.12 | 42,422.9017 | 261,805,999 | 34.66% | 0.00% |
| Sept. 4, 2025 | Cuffe Michael S. | EVP and Chief Clinical Officer | F | Common Stock | 7084 | $411.59 | 35,338.9017 | 261,805,999 | 16.70% | 0.00% |
| July 29, 2025 | CHIDSEY JOHN | Not found | A | Common Stock | 496 | $0.00 | 524.0000 | 261,805,999 | 1771.43% | 0.00% |
| May 13, 2025 | Foster Jon M | EVP and COO | G | Common Stock | 2075 | $0.00 | 187,379.0000 | 261,805,999 | 1.10% | 0.00% |
| May 13, 2025 | Foster Jon M | EVP and COO | J | Common Stock | 15925 | $367.20 | 171,454.0000 | 261,805,999 | 8.50% | 0.01% |
| May 13, 2025 | Foster Jon M | EVP and COO | J | Common Stock | 15925 | $367.20 | 171,454.0000 | 261,805,999 | 10.24% | 0.01% |
| May 13, 2025 | HAZEN SAMUEL N | CEO | G | Common Stock | 90076 | $0.00 | 1,333,636.0000 | 261,805,999 | 6.33% | 0.03% |
| May 13, 2025 | HAZEN SAMUEL N | CEO | G | Common Stock | 90076 | $0.00 | 1,333,636.0000 | 261,805,999 | 7.24% | 0.03% |
| May 13, 2025 | Foster Jon M | EVP and COO | S | Common Stock | 15698 | $369.32 | 172,534.0000 | 261,805,999 | 8.34% | 0.01% |
| May 13, 2025 | Foster Jon M | EVP and COO | G | Common Stock | 1080 | $0.00 | 171,454.0000 | 261,805,999 | 0.63% | 0.00% |
| May 13, 2025 | Foster Jon M | EVP and COO | G | Common Stock | 1080 | $0.00 | 171,454.0000 | 261,805,999 | 0.63% | 0.00% |
| May 13, 2025 | Foster Jon M | EVP and COO | G | Common Stock | 2075 | $0.00 | 155,529.0000 | 261,805,999 | 1.35% | 0.00% |
| May 7, 2025 | Marks Mike A | EVP and CFO | G | Common Stock | 144 | $0.00 | 69,905.0000 | 261,805,999 | 0.21% | 0.00% |
| May 6, 2025 | Marks Mike A | EVP and CFO | G | Common Stock | 144 | $0.00 | 70,049.0000 | 261,805,999 | 0.21% | 0.00% |
| May 6, 2025 | Marks Mike A | EVP and CFO | J | Common Stock | 288 | $353.58 | 70,193.0000 | 261,805,999 | 0.41% | 0.00% |
| May 6, 2025 | Marks Mike A | EVP and CFO | J | Common Stock | 288 | $353.58 | 69,439.0000 | 261,805,999 | 0.41% | 0.00% |
| May 6, 2025 | Marks Mike A | EVP and CFO | G | Common Stock | 466 | $0.00 | 70,371.0000 | 261,805,999 | 0.67% | 0.00% |
| May 7, 2025 | Marks Mike A | EVP and CFO | G | Common Stock | 181 | $0.00 | 70,190.0000 | 261,805,999 | 0.26% | 0.00% |
| May 7, 2025 | Marks Mike A | EVP and CFO | G | Common Stock | 181 | $0.00 | 69,620.0000 | 261,805,999 | 0.26% | 0.00% |
| May 6, 2025 | Marks Mike A | EVP and CFO | G | Common Stock | 466 | $0.00 | 69,905.0000 | 261,805,999 | 0.66% | 0.00% |
| May 7, 2025 | Marks Mike A | EVP and CFO | J | Common Stock | 285 | $356.84 | 69,905.0000 | 261,805,999 | 0.41% | 0.00% |
| May 7, 2025 | Marks Mike A | EVP and CFO | J | Common Stock | 285 | $356.84 | 69,905.0000 | 261,805,999 | 0.41% | 0.00% |
| April 29, 2025 | Smith Andrea B | Not found | A | Common Stock | 645 | $0.00 | 4,239.0000 | 261,805,999 | 17.95% | 0.00% |
| April 29, 2025 | Frist William R | Not found | A | Common Stock, par value $0.01 per share | 1026 | $0.00 | 51,433,524.9593 | 261,805,999 | 0.00% | 0.00% |
| April 30, 2025 | Frist William R | Not found | J | Common Stock, par value $0.01 per share | 10505 | $340.60 | 51,433,524.9593 | 261,805,999 | 0.02% | 0.00% |
| April 29, 2025 | DEPARLE NANCY ANN | Not found | A | Common Stock | 645 | $0.00 | 21,401.0000 | 261,805,999 | 3.11% | 0.00% |
| April 29, 2025 | Johnston Hugh F | Not found | A | Common Stock | 1026 | $0.00 | 3,666.0000 | 261,805,999 | 38.86% | 0.00% |
| April 29, 2025 | MICHELSON MICHAEL W | Not found | A | Common Stock | 1173 | $0.00 | 11,651.0000 | 261,805,999 | 11.19% | 0.00% |
| April 29, 2025 | Riley Wayne Joseph | Not found | A | Common Stock | 645 | $0.00 | 14,520.0000 | 261,805,999 | 4.65% | 0.00% |
| April 29, 2025 | Dennis Robert J | Not found | A | Common Stock | 1026 | $0.00 | 26,601.0000 | 261,805,999 | 4.01% | 0.00% |
| April 29, 2025 | FRIST THOMAS F III | Not found | A | Common Stock, par value $0.01 per share | 1320 | $0.00 | 43,653,845.3079 | 261,805,999 | 0.00% | 0.00% |
| Feb. 14, 2012 | BANK OF AMERICA CORP /DE/ | Not found | S | Common Stock | 32 | $25.17 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 25, 2012 | BANK OF AMERICA CORP /DE/ | Not found | P | Common Stock | 100 | $26.58 | 0.0000 | 0 | 0.00% | 0.00% |
| Jan. 25, 2012 | BANK OF AMERICA CORP /DE/ | Not found | S | Common Stock | 100 | $26.59 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 25, 2012 | BANK OF AMERICA CORP /DE/ | Not found | P | Common Stock | 100 | $26.59 | 0.0000 | 0 | 0.00% | 0.00% |
| Feb. 1, 2012 | BANK OF AMERICA CORP /DE/ | Not found | S | Common Stock | 148 | $25.15 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 2, 2012 | BANK OF AMERICA CORP /DE/ | Not found | P | Common Stock | 148 | $24.91 | 0.0000 | 0 | 0.00% | 0.00% |
| Feb. 3, 2012 | BANK OF AMERICA CORP /DE/ | Not found | P | Common Stock | 1 | $26.27 | 0.0000 | 0 | 0.00% | 0.00% |
| Feb. 7, 2012 | BANK OF AMERICA CORP /DE/ | Not found | P | Common Stock | 32 | $29.00 | 0.0000 | 0 | 0.00% | 0.00% |
| Feb. 13, 2012 | BANK OF AMERICA CORP /DE/ | Not found | P | Common Stock | 1 | $27.78 | 0.0000 | 0 | 0.00% | 0.00% |
| Feb. 14, 2012 | BANK OF AMERICA CORP /DE/ | Not found | S | Common Stock | 1 | $25.10 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 17, 2012 | BANK OF AMERICA CORP /DE/ | Not found | S | Common Stock | 1 | $25.16 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 22, 2012 | BANK OF AMERICA CORP /DE/ | Not found | S | Common Stock | 200 | $25.41 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 22, 2012 | BANK OF AMERICA CORP /DE/ | Not found | P | Common Stock | 200 | $25.46 | 0.0000 | 0 | 0.00% | 0.00% |
| March 8, 2012 | BANK OF AMERICA CORP /DE/ | Not found | P | Common Stock | 1580 | $25.28 | 0.0000 | 0 | 0.00% | 0.00% |
| March 8, 2012 | BANK OF AMERICA CORP /DE/ | Not found | S | Common Stock | 80 | $25.31 | 0.0000 | 0 | 100.00% | 0.00% |
| March 8, 2012 | BANK OF AMERICA CORP /DE/ | Not found | S | Common Stock | 1300 | $25.31 | 0.0000 | 0 | 100.00% | 0.00% |
| March 8, 2012 | BANK OF AMERICA CORP /DE/ | Not found | S | Common Stock | 100 | $25.32 | 0.0000 | 0 | 100.00% | 0.00% |
| March 8, 2012 | BANK OF AMERICA CORP /DE/ | Not found | S | Common Stock | 100 | $25.32 | 0.0000 | 0 | 100.00% | 0.00% |
| March 9, 2012 | BANK OF AMERICA CORP /DE/ | Not found | P | Common Stock | 2 | $25.63 | 0.0000 | 0 | 0.00% | 0.00% |
| March 15, 2012 | BANK OF AMERICA CORP /DE/ | Not found | S | Common Stock | 2 | $25.34 | 0.0000 | 0 | 100.00% | 0.00% |
| March 16, 2012 | BANK OF AMERICA CORP /DE/ | Not found | S | Common Stock | 25 | $25.33 | 0.0000 | 0 | 100.00% | 0.00% |
| March 19, 2012 | BANK OF AMERICA CORP /DE/ | Not found | P | Common Stock | 25 | $25.18 | 0.0000 | 0 | 0.00% | 0.00% |
| April 3, 2012 | BANK OF AMERICA CORP /DE/ | Not found | S | Common Stock | 112 | $26.83 | 0.0000 | 0 | 100.00% | 0.00% |
| April 3, 2012 | BANK OF AMERICA CORP /DE/ | Not found | S | Common Stock | 300 | $26.83 | 0.0000 | 0 | 100.00% | 0.00% |
| July 26, 2011 | BANK OF AMERICA CORP /DE/ | Not found | P | Common Stock | 670 | $27.97 | 0.0000 | 0 | 0.00% | 0.00% |
| Jan. 10, 2012 | BANK OF AMERICA CORP /DE/ | Not found | S | Common Stock | 477 | $21.90 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 13, 2012 | BANK OF AMERICA CORP /DE/ | Not found | P | Common Stock | 477 | $23.29 | 0.0000 | 0 | 0.00% | 0.00% |
| Jan. 25, 2012 | BANK OF AMERICA CORP /DE/ | Not found | S | Common Stock | 100 | $26.58 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 25, 2012 | BANK OF AMERICA CORP /DE/ | Not found | P | Common Stock | 100 | $26.58 | 0.0000 | 0 | 0.00% | 0.00% |
| Jan. 25, 2012 | BANK OF AMERICA CORP /DE/ | Not found | S | Common Stock | 100 | $26.58 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 13, 2025 | Berres Jennifer | SVP & Chief Human Res. Officer | A | Common Stock | 1588 | $0.00 | 25,352.0000 | 261,805,999 | 6.68% | 0.00% |
| Feb. 13, 2025 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | F | Common Stock | 531 | $321.92 | 5,624.0000 | 261,805,999 | 8.63% | 0.00% |
| Feb. 13, 2025 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | A | Common Stock | 2117 | $0.00 | 6,155.0000 | 261,805,999 | 52.43% | 0.00% |
| Feb. 13, 2025 | Mosier Sammie S | SVP & Chief Nurse Executive | F | Common Stock | 227 | $321.92 | 11,113.0000 | 261,805,999 | 2.00% | 0.00% |
| Feb. 13, 2025 | Mosier Sammie S | SVP & Chief Nurse Executive | A | Common Stock | 845 | $0.00 | 11,340.0000 | 261,805,999 | 8.05% | 0.00% |
| Feb. 13, 2025 | Wyatt Christopher F. | SVP & Controller | F | Common Stock | 227 | $321.92 | 41,067.0000 | 261,805,999 | 0.55% | 0.00% |
| Feb. 13, 2025 | Wyatt Christopher F. | SVP & Controller | A | Common Stock | 845 | $0.00 | 41,294.0000 | 261,805,999 | 2.09% | 0.00% |
| Feb. 14, 2025 | Berres Jennifer | SVP & Chief Human Res. Officer | S | Common Stock | 5378 | $322.31 | 15,412.0000 | 261,805,999 | 25.87% | 0.00% |
| Feb. 14, 2025 | Berres Jennifer | SVP & Chief Human Res. Officer | S | Common Stock | 4155 | $322.96 | 20,790.0000 | 261,805,999 | 16.66% | 0.00% |
| Feb. 13, 2025 | Berres Jennifer | SVP & Chief Human Res. Officer | F | Common Stock | 407 | $321.92 | 24,945.0000 | 261,805,999 | 1.61% | 0.00% |
| Feb. 13, 2025 | Marks Mike A | EVP and CFO | A | Common Stock | 638 | $0.00 | 70,365.0000 | 261,805,999 | 0.91% | 0.00% |
| Feb. 13, 2025 | Marks Mike A | EVP and CFO | F | Common Stock | 172 | $321.92 | 70,193.0000 | 261,805,999 | 0.24% | 0.00% |
| Feb. 13, 2025 | HAZEN SAMUEL N | CEO | A | Common Stock | 13218 | $0.00 | 1,338,378.0000 | 261,805,999 | 1.00% | 0.01% |
| Feb. 13, 2025 | HAZEN SAMUEL N | CEO | F | Common Stock | 4742 | $321.92 | 1,333,636.0000 | 261,805,999 | 0.35% | 0.00% |
| Feb. 13, 2025 | Foster Jon M | EVP and COO | A | Common Stock | 2750 | $0.00 | 167,851.0000 | 261,805,999 | 1.67% | 0.00% |
| Feb. 13, 2025 | Foster Jon M | EVP and COO | F | Common Stock | 684 | $321.92 | 167,167.0000 | 261,805,999 | 0.41% | 0.00% |
| Feb. 13, 2025 | Cuffe Michael S. | EVP and Chief Clinical Officer | A | Common Stock | 2330 | $0.00 | 32,008.2085 | 261,805,999 | 7.85% | 0.00% |
| Feb. 13, 2025 | Cuffe Michael S. | EVP and Chief Clinical Officer | F | Common Stock | 583 | $321.92 | 31,425.2085 | 261,805,999 | 1.82% | 0.00% |
| Feb. 7, 2025 | Berres Jennifer | SVP & Chief Human Res. Officer | F | Common Stock | 6747 | $322.05 | 23,764.0000 | 261,805,999 | 22.11% | 0.00% |
| Feb. 7, 2025 | Berres Jennifer | SVP & Chief Human Res. Officer | M | Common Stock | 7440 | $101.16 | 26,171.0000 | 261,805,999 | 39.72% | 0.00% |
| Feb. 7, 2025 | Berres Jennifer | SVP & Chief Human Res. Officer | M | Stock Appreciation Right | 4340 | $0.00 | 0.0000 | 261,805,999 | 100.00% | 0.00% |
| Feb. 7, 2025 | Berres Jennifer | SVP & Chief Human Res. Officer | M | Stock Appreciation Right | 7440 | $0.00 | 0.0000 | 261,805,999 | 100.00% | 0.00% |
| Feb. 7, 2025 | Berres Jennifer | SVP & Chief Human Res. Officer | M | Common Stock | 4340 | $139.06 | 30,511.0000 | 261,805,999 | 16.58% | 0.00% |
| Feb. 3, 2025 | Mosier Sammie S | SVP & Chief Nurse Executive | M | Restricted Stock Units | 138 | $0.00 | 0.0000 | 261,805,999 | 100.00% | 0.00% |
| Feb. 3, 2025 | Mosier Sammie S | SVP & Chief Nurse Executive | F | Common Stock | 41 | $334.30 | 10,495.0000 | 261,805,999 | 0.39% | 0.00% |
| Feb. 3, 2025 | Mosier Sammie S | SVP & Chief Nurse Executive | M | Common Stock | 138 | $0.00 | 10,536.0000 | 261,805,999 | 1.33% | 0.00% |
| Jan. 28, 2025 | Marks Mike A | EVP and CFO | A | Stock Appreciation Right | 15639 | $0.00 | 15,639.0000 | 261,805,999 | 9999.99% | 0.01% |
| Jan. 28, 2025 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | A | Stock Appreciation Right | 11171 | $0.00 | 11,171.0000 | 261,805,999 | 9999.99% | 0.00% |
| Jan. 28, 2025 | Mosier Sammie S | SVP & Chief Nurse Executive | A | Stock Appreciation Right | 4469 | $0.00 | 4,469.0000 | 261,805,999 | 9999.99% | 0.00% |
| Jan. 28, 2025 | Wyatt Christopher F. | SVP & Controller | A | Stock Appreciation Right | 3575 | $0.00 | 3,575.0000 | 261,805,999 | 9999.99% | 0.00% |
| Jan. 28, 2025 | Berres Jennifer | SVP & Chief Human Res. Officer | A | Stock Appreciation Right | 8490 | $0.00 | 8,490.0000 | 261,805,999 | 9999.99% | 0.00% |
| Jan. 28, 2025 | Cuffe Michael S. | EVP and Chief Clinical Officer | A | Stock Appreciation Right | 11171 | $0.00 | 11,171.0000 | 261,805,999 | 9999.99% | 0.00% |
| Jan. 28, 2025 | Foster Jon M | EVP and COO | A | Stock Appreciation Right | 16756 | $0.00 | 16,756.0000 | 261,805,999 | 9999.99% | 0.01% |
| Jan. 28, 2025 | HAZEN SAMUEL N | CEO | A | Stock Appreciation Right | 74620 | $0.00 | 74,620.0000 | 261,805,999 | 9999.99% | 0.03% |
| May 15, 2024 | Foster Jon M | EVP and COO | G | Common Stock | 5350 | $0.00 | 147,101.0000 | 276,412,000 | 3.51% | 0.00% |
| Nov. 14, 2024 | Foster Jon M | EVP and COO | M | Stock Appreciation Right | 36600 | $0.00 | 0.0000 | 263,987,000 | 100.00% | 0.01% |
| Nov. 14, 2024 | Foster Jon M | EVP and COO | F | Common Stock | 20902 | $345.51 | 165,101.0000 | 263,987,000 | 11.24% | 0.01% |
| Nov. 14, 2024 | Foster Jon M | EVP and COO | M | Common Stock | 36600 | $101.16 | 186,003.0000 | 263,987,000 | 24.50% | 0.01% |
| Nov. 14, 2024 | Foster Jon M | EVP and COO | G | Common Stock | 18000 | $0.00 | 165,101.0000 | 263,987,000 | 12.24% | 0.01% |
| Nov. 14, 2024 | Foster Jon M | EVP and COO | G | Common Stock | 18000 | $0.00 | 149,403.0000 | 263,987,000 | 10.75% | 0.01% |
| Nov. 14, 2024 | Foster Jon M | EVP and COO | G | Common Stock | 1955 | $0.00 | 165,101.0000 | 263,987,000 | 1.20% | 0.00% |
| Nov. 14, 2024 | Foster Jon M | EVP and COO | G | Common Stock | 1955 | $0.00 | 167,403.0000 | 263,987,000 | 1.15% | 0.00% |
| Nov. 14, 2024 | Foster Jon M | EVP and COO | J | Common Stock | 9502 | $352.74 | 163,146.0000 | 263,987,000 | 6.18% | 0.00% |
| Nov. 14, 2024 | Foster Jon M | EVP and COO | J | Common Stock | 9502 | $352.74 | 169,358.0000 | 263,987,000 | 5.31% | 0.00% |
| May 15, 2024 | Foster Jon M | EVP and COO | G | Common Stock | 5350 | $0.00 | 165,101.0000 | 276,412,000 | 3.35% | 0.00% |
| Nov. 14, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | S | Common Stock | 1474 | $357.99 | 9,454.0000 | 263,987,000 | 13.49% | 0.00% |
| Nov. 14, 2024 | Billington Phillip G | SVP-Internal Audit Services | S | Common Stock | 3897 | $350.00 | 52,702.0749 | 263,987,000 | 6.89% | 0.00% |
| Nov. 12, 2024 | Billington Phillip G | SVP-Internal Audit Services | M | Common Stock | 8000 | $68.96 | 60,702.0749 | 263,987,000 | 15.18% | 0.00% |
| Nov. 12, 2024 | Billington Phillip G | SVP-Internal Audit Services | F | Common Stock | 4103 | $350.53 | 56,599.0749 | 263,987,000 | 6.76% | 0.00% |
| Nov. 12, 2024 | Billington Phillip G | SVP-Internal Audit Services | M | Stock Appreciation Right | 8000 | $0.00 | 0.0000 | 263,987,000 | 100.00% | 0.00% |
| Nov. 12, 2024 | Akdamar Erol R | Group President | M | Common Stock | 20000 | $68.96 | 140,497.0000 | 263,987,000 | 16.60% | 0.01% |
| Nov. 12, 2024 | Akdamar Erol R | Group President | F | Common Stock | 10257 | $350.53 | 130,240.0000 | 263,987,000 | 7.30% | 0.00% |
| Nov. 14, 2024 | Akdamar Erol R | Group President | S | Common Stock | 2900 | $353.00 | 127,340.0000 | 263,987,000 | 2.23% | 0.00% |
| Nov. 12, 2024 | Akdamar Erol R | Group President | M | Stock Appreciation Right | 20000 | $0.00 | 0.0000 | 263,987,000 | 100.00% | 0.01% |
| Nov. 11, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | M | Common Stock | 4710 | $173.12 | 14,164.0000 | 263,987,000 | 49.82% | 0.00% |
| Nov. 11, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | M | Stock Appreciation Right | 4710 | $0.00 | 1,570.0000 | 263,987,000 | 75.00% | 0.00% |
| Nov. 11, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | F | Common Stock | 3236 | $357.99 | 10,928.0000 | 263,987,000 | 22.85% | 0.00% |
| Oct. 30, 2024 | Elcan Patricia F | TenPercentOwner | J | Common Stock, par value $0.01 per share | 138000 | $361.55 | 47,330,880.1185 | 263,987,000 | 0.29% | 0.05% |
| Oct. 30, 2024 | Elcan Patricia F | TenPercentOwner | J | Common Stock, par value $0.01 per share | 138000 | $361.55 | 46,692,306.1544 | 263,987,000 | 0.30% | 0.05% |
| Oct. 30, 2024 | Elcan Patricia F | TenPercentOwner | J | Common Stock, par value $0.01 per share | 244626 | $361.55 | 47,096,818.2541 | 263,987,000 | 0.52% | 0.09% |
| Oct. 30, 2024 | Elcan Patricia F | TenPercentOwner | J | Common Stock, par value $0.01 per share | 244626 | $361.55 | 46,053,732.1903 | 263,987,000 | 0.53% | 0.09% |
| Oct. 30, 2024 | Elcan Patricia F | TenPercentOwner | J | Common Stock, par value $0.01 per share | 638574 | $361.55 | 46,692,306.1544 | 263,987,000 | 1.39% | 0.24% |
| Oct. 30, 2024 | Elcan Patricia F | TenPercentOwner | J | Common Stock, par value $0.01 per share | 638574 | $361.55 | 46,692,306.1544 | 263,987,000 | 1.35% | 0.24% |
| Sept. 10, 2024 | Cuffe Michael S. | EVP and Chief Clinical Officer | M | Stock Appreciation Right | 22080 | $0.00 | 0.0000 | 276,412,000 | 100.00% | 0.01% |
| Sept. 10, 2024 | Cuffe Michael S. | EVP and Chief Clinical Officer | F | Common Stock | 13722 | $386.43 | 38,036.2085 | 276,412,000 | 26.51% | 0.00% |
| Sept. 12, 2024 | Cuffe Michael S. | EVP and Chief Clinical Officer | S | Common Stock | 8358 | $385.42 | 29,678.2085 | 276,412,000 | 21.97% | 0.00% |
| Sept. 10, 2024 | Cuffe Michael S. | EVP and Chief Clinical Officer | M | Common Stock | 22080 | $145.24 | 51,758.2085 | 276,412,000 | 74.40% | 0.01% |
| Aug. 8, 2024 | Marks Mike A | EVP and CFO | G | Common Stock | 2237 | $0.00 | 69,727.0000 | 276,412,000 | 3.31% | 0.00% |
| Aug. 8, 2024 | Marks Mike A | EVP and CFO | G | Common Stock | 2237 | $0.00 | 69,727.0000 | 276,412,000 | 3.11% | 0.00% |
| Aug. 6, 2024 | HAZEN SAMUEL N | CEO | G | Common Stock | 12084 | $0.00 | 1,328,172.0000 | 276,412,000 | 0.90% | 0.00% |
| Aug. 8, 2024 | HAZEN SAMUEL N | CEO | G | Common Stock | 7115 | $0.00 | 1,325,160.0000 | 276,412,000 | 0.54% | 0.00% |
| Aug. 6, 2024 | HAZEN SAMUEL N | CEO | G | Common Stock | 7115 | $0.00 | 1,340,256.0000 | 276,412,000 | 0.53% | 0.00% |
| Aug. 6, 2024 | HAZEN SAMUEL N | CEO | G | Common Stock | 7115 | $0.00 | 1,332,275.0000 | 276,412,000 | 0.54% | 0.00% |
| Aug. 6, 2024 | HAZEN SAMUEL N | CEO | G | Common Stock | 12084 | $0.00 | 1,325,160.0000 | 276,412,000 | 0.92% | 0.00% |
| Aug. 6, 2024 | HAZEN SAMUEL N | CEO | G | Common Stock | 3012 | $0.00 | 1,325,160.0000 | 276,412,000 | 0.23% | 0.00% |
| Aug. 6, 2024 | HAZEN SAMUEL N | CEO | G | Common Stock | 3012 | $0.00 | 1,325,160.0000 | 276,412,000 | 0.23% | 0.00% |
| Aug. 8, 2024 | HAZEN SAMUEL N | CEO | G | Common Stock | 7115 | $0.00 | 1,325,160.0000 | 276,412,000 | 0.53% | 0.00% |
| Aug. 5, 2024 | Sowell Joseph A III | SVP; Chief Development Officer | G | Common Stock | 13367 | $0.00 | 56,297.0000 | 276,412,000 | 19.19% | 0.00% |
| Aug. 5, 2024 | Sowell Joseph A III | SVP; Chief Development Officer | G | Common Stock | 13367 | $0.00 | 56,297.0000 | 276,412,000 | 31.14% | 0.00% |
| July 31, 2024 | McManus Timothy M | Group President | M | Stock Appreciation Right | 7500 | $0.00 | 7,440.0000 | 276,412,000 | 50.20% | 0.00% |
| July 31, 2024 | McManus Timothy M | Group President | F | Common Stock | 3919 | $363.05 | 27,008.4141 | 276,412,000 | 12.67% | 0.00% |
| July 31, 2024 | McManus Timothy M | Group President | M | Common Stock | 7500 | $77.13 | 30,927.4141 | 276,412,000 | 32.01% | 0.00% |
| July 29, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | F | Common Stock | 5293 | $358.73 | 14,305.0000 | 276,412,000 | 27.01% | 0.00% |
| July 29, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | M | Common Stock | 8280 | $145.24 | 19,598.0000 | 276,412,000 | 73.16% | 0.00% |
| July 29, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | S | Common Stock | 1864 | $359.92 | 12,441.0000 | 276,412,000 | 13.03% | 0.00% |
| July 29, 2024 | Reiner Deborah M | SVP - Mktg. & Communications | S | Common Stock | 3314 | $359.96 | 3,510.0000 | 276,412,000 | 48.56% | 0.00% |
| July 29, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | M | Stock Appreciation Right | 8280 | $0.00 | 0.0000 | 276,412,000 | 100.00% | 0.00% |
| July 31, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | S | Common Stock | 2987 | $363.51 | 9,454.0000 | 276,412,000 | 24.01% | 0.00% |
| July 25, 2024 | Torres Kathryn A. | SVP-Payer Contracting & Align. | S | Common Stock | 1857 | $355.05 | 17,755.0000 | 276,412,000 | 9.47% | 0.00% |
| July 25, 2024 | Wyatt Christopher F. | SVP & Controller | M | Stock Appreciation Right | 9300 | $0.00 | 0.0000 | 276,412,000 | 100.00% | 0.00% |
| July 25, 2024 | Wyatt Christopher F. | SVP & Controller | M | Common Stock | 9300 | $101.16 | 49,727.0000 | 276,412,000 | 23.00% | 0.00% |
| July 29, 2024 | Wyatt Christopher F. | SVP & Controller | S | Common Stock | 4000 | $360.20 | 40,449.0000 | 276,412,000 | 9.00% | 0.00% |
| July 25, 2024 | Wyatt Christopher F. | SVP & Controller | F | Common Stock | 5278 | $352.79 | 44,449.0000 | 276,412,000 | 10.61% | 0.00% |
| May 16, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | S | Common Stock | 3204 | $326.30 | 9,454.0000 | 276,412,000 | 25.31% | 0.00% |
| May 17, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | M | Common Stock | 3040 | $101.16 | 12,494.0000 | 276,412,000 | 32.16% | 0.00% |
| May 17, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | F | Common Stock | 2861 | $322.86 | 11,318.0000 | 276,412,000 | 20.18% | 0.00% |
| May 17, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | M | Stock Appreciation Right | 3040 | $0.00 | 0.0000 | 276,412,000 | 100.00% | 0.00% |
| May 17, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | M | Stock Appreciation Right | 1685 | $0.00 | 12,045.0000 | 276,412,000 | 12.27% | 0.00% |
| May 17, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | M | Common Stock | 1685 | $133.53 | 14,179.0000 | 276,412,000 | 13.49% | 0.00% |
| May 15, 2024 | Sowell Joseph A III | SVP; Chief Development Officer | M | Stock Appreciation Right | 19000 | $0.00 | 0.0000 | 276,412,000 | 100.00% | 0.01% |
| May 15, 2024 | Torres Kathryn A. | SVP-Payer Contracting & Align. | S | Common Stock | 1863 | $326.18 | 19,612.0000 | 276,412,000 | 8.68% | 0.00% |
| May 15, 2024 | Sowell Joseph A III | SVP; Chief Development Officer | M | Common Stock | 19000 | $68.96 | 66,205.0000 | 276,412,000 | 40.25% | 0.01% |
| May 15, 2024 | Sowell Joseph A III | SVP; Chief Development Officer | F | Common Stock | 9908 | $326.96 | 56,297.0000 | 276,412,000 | 14.97% | 0.00% |
| May 15, 2024 | Foster Jon M | EVP and COO | M | Common Stock | 11955 | $69.58 | 163,136.0000 | 276,412,000 | 7.91% | 0.00% |
| May 15, 2024 | Foster Jon M | EVP and COO | M | Common Stock | 27510 | $81.96 | 190,646.0000 | 276,412,000 | 16.86% | 0.01% |
| May 15, 2024 | Foster Jon M | EVP and COO | F | Common Stock | 21258 | $326.96 | 169,388.0000 | 276,412,000 | 11.15% | 0.01% |
| May 15, 2024 | Foster Jon M | EVP and COO | M | Stock Appreciation Right | 11955 | $0.00 | 0.0000 | 276,412,000 | 100.00% | 0.00% |
| May 15, 2024 | Foster Jon M | EVP and COO | M | Stock Appreciation Right | 27510 | $0.00 | 0.0000 | 276,412,000 | 100.00% | 0.01% |
| May 9, 2024 | Cuffe Michael S. | EVP and Chief Clinical Officer | S | Common Stock | 6311 | $316.88 | 29,623.9692 | 276,412,000 | 17.56% | 0.00% |
| May 9, 2024 | Cohen Jeffrey E. | SVP-Government Relations | S | Common Stock | 1650 | $313.00 | 5,185.0000 | 276,412,000 | 24.14% | 0.00% |
| May 9, 2024 | Akdamar Erol R | Group President | G | Common Stock | 5139 | $0.00 | 120,497.0000 | 276,412,000 | 4.09% | 0.00% |
| May 9, 2024 | Akdamar Erol R | Group President | G | Common Stock | 5139 | $0.00 | 120,497.0000 | 276,412,000 | 4.45% | 0.00% |
| May 6, 2024 | Cuffe Michael S. | EVP and Chief Clinical Officer | S | Common Stock | 1600 | $309.00 | 34,123.9692 | 276,412,000 | 4.48% | 0.00% |
| May 7, 2024 | Cuffe Michael S. | EVP and Chief Clinical Officer | M | Common Stock | 18660 | $139.06 | 52,783.9692 | 276,412,000 | 54.68% | 0.01% |
| May 7, 2024 | Cuffe Michael S. | EVP and Chief Clinical Officer | F | Common Stock | 12349 | $314.45 | 40,434.9692 | 276,412,000 | 23.40% | 0.00% |
| May 8, 2024 | Cuffe Michael S. | EVP and Chief Clinical Officer | G | Common Stock | 4500 | $0.00 | 35,934.9692 | 276,412,000 | 11.13% | 0.00% |
| May 7, 2024 | Cuffe Michael S. | EVP and Chief Clinical Officer | M | Stock Appreciation Right | 18660 | $0.00 | 0.0000 | 276,412,000 | 100.00% | 0.01% |
| May 2, 2024 | Torres Kathryn A. | SVP-Payer Contracting & Align. | S | Common Stock | 973 | $312.00 | 22,365.0000 | 276,412,000 | 4.17% | 0.00% |
| May 3, 2024 | Torres Kathryn A. | SVP-Payer Contracting & Align. | S | Common Stock | 890 | $312.00 | 21,475.0000 | 276,412,000 | 3.98% | 0.00% |
| April 29, 2024 | Marks Mike A | EVP and CFO | A | Stock Appreciation Right | 9096 | $0.00 | 9,096.0000 | 276,412,000 | 9999.99% | 0.00% |
| May 1, 2024 | Marks Mike A | EVP and CFO | G | Common Stock | 566 | $0.00 | 69,727.0000 | 276,412,000 | 0.81% | 0.00% |
| April 29, 2024 | FRIST THOMAS F III | Director | A | Common Stock, par value $0.01 per share | 1284 | $0.00 | 43,652,525.3079 | 276,412,000 | 0.00% | 0.00% |
| April 29, 2024 | Frist William R | Director | A | Common Stock, par value $0.01 per share | 963 | $0.00 | 51,432,498.9593 | 276,412,000 | 0.00% | 0.00% |
| April 29, 2024 | Smith Andrea B | Director | A | Common Stock | 610 | $0.00 | 3,594.0000 | 276,412,000 | 20.44% | 0.00% |
| April 29, 2024 | Riley Wayne Joseph | Director | A | Common Stock | 610 | $0.00 | 13,875.0000 | 276,412,000 | 4.60% | 0.00% |
| April 29, 2024 | MICHELSON MICHAEL W | Director | A | Common Stock | 1091 | $0.00 | 10,478.0000 | 276,412,000 | 11.62% | 0.00% |
| April 29, 2024 | Johnston Hugh F | Director | A | Common Stock | 610 | $0.00 | 2,640.0000 | 276,412,000 | 30.05% | 0.00% |
| April 29, 2024 | DEPARLE NANCY ANN | Director | A | Common Stock | 610 | $0.00 | 20,756.0000 | 276,412,000 | 3.03% | 0.00% |
| April 29, 2024 | Dennis Robert J | Director | A | Common Stock | 963 | $0.00 | 25,575.0000 | 276,412,000 | 3.91% | 0.00% |
| April 29, 2024 | CROFTON MEG | Director | A | Common Stock | 610 | $0.00 | 6,331.0000 | 276,412,000 | 10.66% | 0.00% |
| April 29, 2024 | McAlevey Michael R | EVP - Chief Legal & Admin Off | A | Stock Appreciation Right | 2274 | $0.00 | 2,274.0000 | 276,412,000 | 9999.99% | 0.00% |
| March 20, 2024 | Wasserman Chad J | SVP and CIO | S | Common Stock | 876 | $330.25 | 1,576.3102 | 276,412,000 | 35.72% | 0.00% |
| March 18, 2024 | Wasserman Chad J | SVP and CIO | M | Common Stock | 2100 | $101.16 | 4,020.3102 | 276,412,000 | 109.36% | 0.00% |
| March 18, 2024 | Wasserman Chad J | SVP and CIO | F | Common Stock | 1224 | $327.17 | 2,796.3102 | 276,412,000 | 30.45% | 0.00% |
| March 18, 2024 | Wasserman Chad J | SVP and CIO | S | Common Stock | 344 | $321.97 | 2,452.3102 | 276,412,000 | 12.30% | 0.00% |
| March 18, 2024 | Wasserman Chad J | SVP and CIO | M | Stock Appreciation Right | 2100 | $0.00 | 4,190.0000 | 276,412,000 | 33.39% | 0.00% |
| Feb. 16, 2024 | RUTHERFORD BILL B | CFO and EVP | F | Common Stock | 8177 | $308.55 | 182,085.0000 | 276,412,000 | 4.30% | 0.00% |
| Feb. 16, 2024 | Akdamar Erol R | Group President | F | Common Stock | 2561 | $308.55 | 120,497.0000 | 276,412,000 | 2.08% | 0.00% |
| Feb. 16, 2024 | Akdamar Erol R | Group President | A | Common Stock | 7700 | $0.00 | 123,058.0000 | 276,412,000 | 6.67% | 0.00% |
| Feb. 16, 2024 | Berres Jennifer | SVP & Chief Human Res. Officer | F | Common Stock | 3240 | $308.55 | 18,731.0000 | 276,412,000 | 14.75% | 0.00% |
| Feb. 16, 2024 | Berres Jennifer | SVP & Chief Human Res. Officer | A | Common Stock | 9420 | $0.00 | 21,971.0000 | 276,412,000 | 75.05% | 0.00% |
| Feb. 16, 2024 | Billington Phillip G | SVP-Internal Audit Services | F | Common Stock | 1022 | $308.55 | 52,618.4544 | 276,412,000 | 1.91% | 0.00% |
| Feb. 16, 2024 | Billington Phillip G | SVP-Internal Audit Services | A | Common Stock | 3780 | $0.00 | 53,640.4544 | 276,412,000 | 7.58% | 0.00% |
| Feb. 16, 2024 | Cohen Jeffrey E. | SVP-Government Relations | F | Common Stock | 1359 | $308.55 | 6,835.0000 | 276,412,000 | 16.59% | 0.00% |
| Feb. 16, 2024 | Cohen Jeffrey E. | SVP-Government Relations | A | Common Stock | 3780 | $0.00 | 8,194.0000 | 276,412,000 | 85.64% | 0.00% |
| Feb. 16, 2024 | Cuffe Michael S. | EVP and Chief Clinical Officer | F | Common Stock | 6212 | $308.55 | 35,696.9672 | 276,412,000 | 14.82% | 0.00% |
| Feb. 16, 2024 | Cuffe Michael S. | EVP and Chief Clinical Officer | A | Common Stock | 4420 | $0.00 | 41,908.9672 | 276,412,000 | 11.79% | 0.00% |
| Feb. 16, 2024 | Cuffe Michael S. | EVP and Chief Clinical Officer | A | Common Stock | 12560 | $0.00 | 37,488.9672 | 276,412,000 | 50.38% | 0.00% |
| Feb. 16, 2024 | Foster Jon M | EVP and COO | F | Common Stock | 5950 | $308.55 | 151,181.0000 | 276,412,000 | 3.79% | 0.00% |
| Feb. 16, 2024 | Foster Jon M | EVP and COO | A | Common Stock | 16320 | $0.00 | 157,131.0000 | 276,412,000 | 11.59% | 0.01% |
| Feb. 16, 2024 | Hammett Richard A | Group President | F | Common Stock | 1762 | $308.55 | 17,936.0000 | 276,412,000 | 8.95% | 0.00% |
| Feb. 16, 2024 | Hammett Richard A | Group President | A | Common Stock | 5500 | $0.00 | 19,698.0000 | 276,412,000 | 38.74% | 0.00% |
| Feb. 16, 2024 | HAZEN SAMUEL N | CEO | F | Common Stock | 30387 | $308.55 | 1,325,160.0000 | 276,412,000 | 2.24% | 0.01% |
| Feb. 16, 2024 | HAZEN SAMUEL N | CEO | A | Common Stock | 78440 | $0.00 | 1,355,547.0000 | 276,412,000 | 6.14% | 0.03% |
| Feb. 16, 2024 | Marks Mike A | SVP-Finance | F | Common Stock | 1022 | $308.55 | 70,293.0000 | 276,412,000 | 1.43% | 0.00% |
| Feb. 16, 2024 | Marks Mike A | SVP-Finance | A | Common Stock | 3780 | $0.00 | 71,315.0000 | 276,412,000 | 5.60% | 0.00% |
| Feb. 16, 2024 | McManus Timothy M | Group President | F | Common Stock | 2002 | $308.55 | 23,427.4141 | 276,412,000 | 7.87% | 0.00% |
| Feb. 16, 2024 | McManus Timothy M | Group President | A | Common Stock | 6280 | $0.00 | 25,429.4141 | 276,412,000 | 32.79% | 0.00% |
| Feb. 16, 2024 | Mosier Sammie S | SVP & Chief Nurse Executive | F | Common Stock | 1068 | $308.55 | 10,398.0000 | 276,412,000 | 9.31% | 0.00% |
| Feb. 16, 2024 | Mosier Sammie S | SVP & Chief Nurse Executive | A | Common Stock | 1620 | $0.00 | 11,466.0000 | 276,412,000 | 16.45% | 0.00% |
| Feb. 16, 2024 | Mosier Sammie S | SVP & Chief Nurse Executive | A | Common Stock | 2200 | $0.00 | 9,846.0000 | 276,412,000 | 28.77% | 0.00% |
| Feb. 16, 2024 | Reiner Deborah M | SVP - Mktg. & Communications | F | Common Stock | 1510 | $308.55 | 6,824.0000 | 276,412,000 | 18.12% | 0.00% |
| Feb. 16, 2024 | Reiner Deborah M | SVP - Mktg. & Communications | A | Common Stock | 5020 | $0.00 | 8,334.0000 | 276,412,000 | 151.48% | 0.00% |
| Feb. 16, 2024 | RUTHERFORD BILL B | CFO and EVP | A | Common Stock | 21980 | $0.00 | 190,262.0000 | 276,412,000 | 13.06% | 0.01% |
| Feb. 16, 2024 | Sowell Joseph A III | SVP; Chief Development Officer | F | Common Stock | 2005 | $308.55 | 47,205.0000 | 276,412,000 | 4.07% | 0.00% |
| Feb. 16, 2024 | Sowell Joseph A III | SVP; Chief Development Officer | A | Common Stock | 6280 | $0.00 | 49,210.0000 | 276,412,000 | 14.63% | 0.00% |
| Feb. 16, 2024 | Torres Kathryn A. | SVP-Payer Contracting & Align. | F | Common Stock | 1976 | $308.55 | 23,338.0000 | 276,412,000 | 7.81% | 0.00% |
| Feb. 16, 2024 | Torres Kathryn A. | SVP-Payer Contracting & Align. | A | Common Stock | 5020 | $0.00 | 25,314.0000 | 276,412,000 | 24.74% | 0.00% |
| Feb. 16, 2024 | Wasserman Chad J | SVP and CIO | F | Common Stock | 499 | $308.55 | 1,920.3102 | 276,412,000 | 20.63% | 0.00% |
| Feb. 16, 2024 | Wasserman Chad J | SVP and CIO | A | Common Stock | 2040 | $0.00 | 2,419.3102 | 276,412,000 | 537.82% | 0.00% |
| Feb. 16, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | F | Common Stock | 1023 | $308.55 | 12,658.0000 | 276,412,000 | 7.48% | 0.00% |
| Feb. 16, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | A | Common Stock | 3780 | $0.00 | 13,681.0000 | 276,412,000 | 38.18% | 0.00% |
| Feb. 16, 2024 | Wyatt Christopher F. | SVP & Controller | F | Common Stock | 1976 | $308.55 | 40,427.0000 | 276,412,000 | 4.66% | 0.00% |
| Feb. 16, 2024 | Wyatt Christopher F. | SVP & Controller | A | Common Stock | 5020 | $0.00 | 42,403.0000 | 276,412,000 | 13.43% | 0.00% |
| Feb. 14, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | G | Common Stock | 349 | $0.00 | 9,901.0000 | 276,412,000 | 3.40% | 0.00% |
| Feb. 9, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | S | Common Stock | 4262 | $306.21 | 10,250.0000 | 276,412,000 | 29.37% | 0.00% |
| Feb. 6, 2024 | Torres Kathryn A. | SVP-Payer Contracting & Align. | M | Common Stock | 2092 | $173.12 | 21,717.0000 | 276,412,000 | 10.66% | 0.00% |
| Feb. 6, 2024 | Torres Kathryn A. | SVP-Payer Contracting & Align. | M | Stock Appreciation Right | 2092 | $0.00 | 2,093.0000 | 276,412,000 | 49.99% | 0.00% |
| Feb. 6, 2024 | Torres Kathryn A. | SVP-Payer Contracting & Align. | F | Common Stock | 1423 | $306.82 | 20,294.0000 | 276,412,000 | 6.55% | 0.00% |
| Feb. 6, 2024 | Akdamar Erol R | Group President | G | Common Stock | 12874 | $0.00 | 115,358.0000 | 276,412,000 | 12.56% | 0.00% |
| Feb. 6, 2024 | Akdamar Erol R | Group President | G | Common Stock | 12874 | $0.00 | 115,358.0000 | 276,412,000 | 10.04% | 0.00% |
| Feb. 5, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | M | Common Stock | 2000 | $101.16 | 18,800.0000 | 276,412,000 | 11.90% | 0.00% |
| Feb. 5, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | M | Common Stock | 4040 | $81.96 | 16,800.0000 | 276,412,000 | 31.66% | 0.00% |
| Feb. 5, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | M | Common Stock | 2510 | $69.58 | 12,760.0000 | 276,412,000 | 24.49% | 0.00% |
| Feb. 5, 2024 | Wyatt Christopher F. | SVP & Controller | S | Common Stock | 4000 | $312.42 | 37,383.0000 | 276,412,000 | 9.67% | 0.00% |
| Feb. 5, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | M | Stock Appreciation Right | 2000 | $0.00 | 3,040.0000 | 276,412,000 | 39.68% | 0.00% |
| Feb. 5, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | M | Stock Appreciation Right | 4040 | $0.00 | 0.0000 | 276,412,000 | 100.00% | 0.00% |
| Feb. 5, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | M | Stock Appreciation Right | 2510 | $0.00 | 0.0000 | 276,412,000 | 100.00% | 0.00% |
| Feb. 5, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | F | Common Stock | 4288 | $310.62 | 14,512.0000 | 276,412,000 | 22.81% | 0.00% |
| Feb. 2, 2024 | RUTHERFORD BILL B | CFO and EVP | F | Common Stock | 9652 | $309.42 | 175,651.0000 | 276,412,000 | 5.21% | 0.00% |
| Feb. 2, 2024 | RUTHERFORD BILL B | CFO and EVP | M | Common Stock | 19100 | $69.58 | 185,303.0000 | 276,412,000 | 11.49% | 0.01% |
| Feb. 2, 2024 | Mosier Sammie S | SVP & Chief Nurse Executive | M | Common Stock | 2775 | $236.61 | 13,052.0000 | 276,412,000 | 27.00% | 0.00% |
| Feb. 2, 2024 | Mosier Sammie S | SVP & Chief Nurse Executive | M | Common Stock | 1340 | $241.81 | 10,277.0000 | 276,412,000 | 14.99% | 0.00% |
| Feb. 2, 2024 | Mosier Sammie S | SVP & Chief Nurse Executive | M | Common Stock | 920 | $173.12 | 8,937.0000 | 276,412,000 | 11.48% | 0.00% |
| Feb. 2, 2024 | RUTHERFORD BILL B | CFO and EVP | M | Stock Appreciation Right | 19100 | $0.00 | 0.0000 | 276,412,000 | 100.00% | 0.01% |
| Feb. 3, 2024 | Wasserman Chad J | SVP and CIO | M | Restricted Stock Units | 127 | $0.00 | 128.0000 | 276,412,000 | 49.80% | 0.00% |
| Feb. 3, 2024 | Wasserman Chad J | SVP and CIO | F | Common Stock | 38 | $309.42 | 379.3102 | 276,412,000 | 9.11% | 0.00% |
| Feb. 3, 2024 | Wasserman Chad J | SVP and CIO | M | Common Stock | 127 | $0.00 | 417.3102 | 276,412,000 | 43.75% | 0.00% |
| Feb. 2, 2024 | Wasserman Chad J | SVP and CIO | S | Common Stock | 652 | $312.04 | 290.3102 | 276,412,000 | 69.19% | 0.00% |
| Feb. 3, 2024 | Mosier Sammie S | SVP & Chief Nurse Executive | M | Restricted Stock Units | 137 | $0.00 | 138.0000 | 276,412,000 | 49.82% | 0.00% |
| Feb. 2, 2024 | Mosier Sammie S | SVP & Chief Nurse Executive | M | Stock Appreciation Right | 1263 | $0.00 | 3,789.0000 | 276,412,000 | 25.00% | 0.00% |
| Feb. 2, 2024 | Mosier Sammie S | SVP & Chief Nurse Executive | M | Stock Appreciation Right | 2775 | $0.00 | 2,775.0000 | 276,412,000 | 50.00% | 0.00% |
| Feb. 2, 2024 | Mosier Sammie S | SVP & Chief Nurse Executive | M | Stock Appreciation Right | 1340 | $0.00 | 1,340.0000 | 276,412,000 | 50.00% | 0.00% |
| Feb. 2, 2024 | Mosier Sammie S | SVP & Chief Nurse Executive | M | Stock Appreciation Right | 920 | $0.00 | 920.0000 | 276,412,000 | 50.00% | 0.00% |
| Feb. 5, 2024 | Mosier Sammie S | SVP & Chief Nurse Executive | S | Common Stock | 1645 | $312.00 | 7,646.0000 | 276,412,000 | 17.71% | 0.00% |
| Feb. 3, 2024 | Mosier Sammie S | SVP & Chief Nurse Executive | F | Common Stock | 34 | $309.42 | 9,291.0000 | 276,412,000 | 0.36% | 0.00% |
| Feb. 3, 2024 | Mosier Sammie S | SVP & Chief Nurse Executive | M | Common Stock | 137 | $0.00 | 9,325.0000 | 276,412,000 | 1.49% | 0.00% |
| Feb. 2, 2024 | Mosier Sammie S | SVP & Chief Nurse Executive | F | Common Stock | 5127 | $309.42 | 9,188.0000 | 276,412,000 | 35.82% | 0.00% |
| Feb. 2, 2024 | Mosier Sammie S | SVP & Chief Nurse Executive | M | Common Stock | 1263 | $253.30 | 14,315.0000 | 276,412,000 | 9.68% | 0.00% |
| Feb. 6, 2024 | RUTHERFORD BILL B | CFO and EVP | S | Common Stock | 6000 | $310.63 | 168,282.0000 | 276,412,000 | 3.44% | 0.00% |
| Feb. 5, 2024 | RUTHERFORD BILL B | CFO and EVP | G | Common Stock | 1194 | $0.00 | 168,282.0000 | 276,412,000 | 0.71% | 0.00% |
| Feb. 5, 2024 | RUTHERFORD BILL B | CFO and EVP | G | Common Stock | 1194 | $0.00 | 174,282.0000 | 276,412,000 | 0.68% | 0.00% |
| Feb. 5, 2024 | RUTHERFORD BILL B | CFO and EVP | G | Common Stock | 175 | $0.00 | 175,476.0000 | 276,412,000 | 0.10% | 0.00% |
| Feb. 1, 2024 | Torres Kathryn A. | SVP-Payer Contracting & Align. | M | Stock Appreciation Right | 2775 | $0.00 | 2,775.0000 | 276,412,000 | 50.00% | 0.00% |
| Jan. 31, 2024 | Wyatt Christopher F. | SVP & Controller | M | Common Stock | 2680 | $81.96 | 38,759.0000 | 276,412,000 | 7.43% | 0.00% |
| Jan. 31, 2024 | Wyatt Christopher F. | SVP & Controller | M | Common Stock | 9000 | $101.16 | 47,759.0000 | 276,412,000 | 23.22% | 0.00% |
| Jan. 31, 2024 | Wyatt Christopher F. | SVP & Controller | F | Common Stock | 6376 | $304.90 | 41,383.0000 | 276,412,000 | 13.35% | 0.00% |
| Jan. 31, 2024 | Wyatt Christopher F. | SVP & Controller | M | Stock Appreciation Right | 2680 | $0.00 | 0.0000 | 276,412,000 | 100.00% | 0.00% |
| Jan. 31, 2024 | Wyatt Christopher F. | SVP & Controller | M | Stock Appreciation Right | 9000 | $0.00 | 9,300.0000 | 276,412,000 | 49.18% | 0.00% |
| Jan. 31, 2024 | Wyatt Christopher F. | SVP & Controller | A | Stock Appreciation Right | 4402 | $0.00 | 4,402.0000 | 276,412,000 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Whalen Kathleen M | SVP & Chief Ethics Officer | A | Stock Appreciation Right | 3302 | $0.00 | 3,302.0000 | 276,412,000 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Torres Kathryn A. | SVP-Payer Contracting & Align. | S | Common Stock | 3861 | $307.00 | 15,899.0000 | 276,412,000 | 19.54% | 0.00% |
| Feb. 1, 2024 | Torres Kathryn A. | SVP-Payer Contracting & Align. | M | Common Stock | 4771 | $145.24 | 20,670.0000 | 276,412,000 | 30.01% | 0.00% |
| Feb. 1, 2024 | Torres Kathryn A. | SVP-Payer Contracting & Align. | M | Common Stock | 4185 | $173.12 | 24,855.0000 | 276,412,000 | 20.25% | 0.00% |
| Feb. 1, 2024 | Torres Kathryn A. | SVP-Payer Contracting & Align. | M | Common Stock | 2775 | $236.61 | 27,630.0000 | 276,412,000 | 11.16% | 0.00% |
| Feb. 1, 2024 | Torres Kathryn A. | SVP-Payer Contracting & Align. | M | Common Stock | 1263 | $253.30 | 28,893.0000 | 276,412,000 | 4.57% | 0.00% |
| Feb. 1, 2024 | Torres Kathryn A. | SVP-Payer Contracting & Align. | F | Common Stock | 9268 | $314.66 | 19,625.0000 | 276,412,000 | 32.08% | 0.00% |
| Jan. 31, 2024 | Torres Kathryn A. | SVP-Payer Contracting & Align. | A | Stock Appreciation Right | 4402 | $0.00 | 4,402.0000 | 276,412,000 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Torres Kathryn A. | SVP-Payer Contracting & Align. | M | Stock Appreciation Right | 4771 | $0.00 | 0.0000 | 276,412,000 | 100.00% | 0.00% |
| Feb. 1, 2024 | Torres Kathryn A. | SVP-Payer Contracting & Align. | M | Stock Appreciation Right | 4185 | $0.00 | 4,185.0000 | 276,412,000 | 50.00% | 0.00% |
| Feb. 1, 2024 | Torres Kathryn A. | SVP-Payer Contracting & Align. | M | Stock Appreciation Right | 1263 | $0.00 | 3,789.0000 | 276,412,000 | 25.00% | 0.00% |
| Jan. 31, 2024 | Sowell Joseph A III | SVP; Chief Development Officer | A | Stock Appreciation Right | 4402 | $0.00 | 4,402.0000 | 276,412,000 | 9999.99% | 0.00% |
| Jan. 31, 2024 | RUTHERFORD BILL B | CFO and EVP | A | Stock Appreciation Right | 20634 | $0.00 | 20,634.0000 | 276,412,000 | 9999.99% | 0.01% |
| Jan. 31, 2024 | Reiner Deborah M | SVP - Mktg. & Communications | A | Stock Appreciation Right | 4402 | $0.00 | 4,402.0000 | 276,412,000 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Mosier Sammie S | SVP & Chief Nurse Executive | A | Stock Appreciation Right | 4402 | $0.00 | 4,402.0000 | 276,412,000 | 9999.99% | 0.00% |
| Jan. 31, 2024 | McManus Timothy M | Group President | A | Stock Appreciation Right | 11005 | $0.00 | 11,005.0000 | 276,412,000 | 9999.99% | 0.00% |
| Jan. 31, 2024 | McAlevey Michael R | SVP & Chief Legal Officer | A | Stock Appreciation Right | 11005 | $0.00 | 11,005.0000 | 276,412,000 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Marks Mike A | SVP-Finance | A | Stock Appreciation Right | 5503 | $0.00 | 5,503.0000 | 276,412,000 | 9999.99% | 0.00% |
| Jan. 31, 2024 | HAZEN SAMUEL N | CEO | A | Stock Appreciation Right | 79784 | $0.00 | 79,784.0000 | 276,412,000 | 9999.99% | 0.03% |
| Jan. 31, 2024 | Hammett Richard A | Group President | A | Stock Appreciation Right | 11005 | $0.00 | 11,005.0000 | 276,412,000 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Foster Jon M | EVP and COO | A | Stock Appreciation Right | 20634 | $0.00 | 20,634.0000 | 276,412,000 | 9999.99% | 0.01% |
| Jan. 31, 2024 | Cuffe Michael S. | EVP and Chief Clinical Officer | G | Common Stock | 728 | $0.00 | 28,128.9672 | 276,412,000 | 2.52% | 0.00% |
| Jan. 31, 2024 | Cuffe Michael S. | EVP and Chief Clinical Officer | S | Common Stock | 3200 | $306.79 | 24,928.9672 | 276,412,000 | 11.38% | 0.00% |
| Jan. 31, 2024 | Cuffe Michael S. | EVP and Chief Clinical Officer | A | Stock Appreciation Right | 12656 | $0.00 | 12,656.0000 | 276,412,000 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Cohen Jeffrey E. | SVP-Government Relations | A | Stock Appreciation Right | 3302 | $0.00 | 3,302.0000 | 276,412,000 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Billington Phillip G | SVP-Internal Audit Services | A | Stock Appreciation Right | 3302 | $0.00 | 3,302.0000 | 276,412,000 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Berres Jennifer | SVP & Chief Human Res. Officer | A | Stock Appreciation Right | 9354 | $0.00 | 9,354.0000 | 276,412,000 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Akdamar Erol R | Group President | A | Stock Appreciation Right | 11005 | $0.00 | 11,005.0000 | 276,412,000 | 9999.99% | 0.00% |
| Jan. 29, 2024 | Hammett Richard A | Group President | M | Common Stock | 600 | $0.00 | 14,362.0000 | 276,412,000 | 4.36% | 0.00% |
| Jan. 29, 2024 | Mosier Sammie S | SVP & Chief Nurse Executive | M | Restricted Stock Units | 323 | $0.00 | 0.0000 | 276,412,000 | 100.00% | 0.00% |
| Jan. 29, 2024 | Mosier Sammie S | SVP & Chief Nurse Executive | F | Common Stock | 96 | $286.73 | 8,017.0000 | 276,412,000 | 1.18% | 0.00% |
| Jan. 29, 2024 | Mosier Sammie S | SVP & Chief Nurse Executive | M | Common Stock | 323 | $0.00 | 8,113.0000 | 276,412,000 | 4.15% | 0.00% |
| Jan. 29, 2024 | Hammett Richard A | Group President | M | Restricted Stock Units | 600 | $0.00 | 0.0000 | 276,412,000 | 100.00% | 0.00% |
| Jan. 29, 2024 | Hammett Richard A | Group President | F | Common Stock | 164 | $286.73 | 14,198.0000 | 276,412,000 | 1.14% | 0.00% |
| Jan. 28, 2024 | McAlevey Michael R | SVP & Chief Legal Officer | M | Common Stock | 1940 | $0.00 | 4,527.0000 | 276,412,000 | 74.99% | 0.00% |
| Jan. 28, 2024 | McAlevey Michael R | SVP & Chief Legal Officer | M | Restricted Stock Units | 1940 | $0.00 | 0.0000 | 276,412,000 | 100.00% | 0.00% |
| Jan. 28, 2024 | McAlevey Michael R | SVP & Chief Legal Officer | F | Common Stock | 489 | $283.43 | 4,038.0000 | 276,412,000 | 10.80% | 0.00% |
| Nov. 13, 2023 | Akdamar Erol R | Group President | M | Common Stock | 26825 | $47.97 | 129,309.0000 | 294,666,000 | 26.17% | 0.01% |
| Nov. 13, 2023 | Akdamar Erol R | Group President | M | Stock Appreciation Right | 12325 | $0.00 | 0.0000 | 294,666,000 | 100.00% | 0.00% |
| Nov. 13, 2023 | Akdamar Erol R | Group President | M | Stock Appreciation Right | 14500 | $0.00 | 0.0000 | 294,666,000 | 100.00% | 0.00% |
| Nov. 13, 2023 | Akdamar Erol R | Group President | F | Common Stock | 13951 | $229.99 | 115,358.0000 | 294,666,000 | 10.79% | 0.00% |
| Nov. 10, 2023 | Billington Phillip G | SVP-Internal Audit Services | M | Common Stock | 12025 | $47.97 | 56,097.4544 | 294,666,000 | 27.28% | 0.00% |
| Nov. 14, 2023 | Sowell Joseph A III | SVP; Chief Development Officer | G | Common Stock | 5159 | $0.00 | 72,701.0000 | 294,666,000 | 7.64% | 0.00% |
| Nov. 14, 2023 | Sowell Joseph A III | SVP; Chief Development Officer | G | Common Stock | 5159 | $0.00 | 72,701.0000 | 294,666,000 | 6.63% | 0.00% |
| Nov. 14, 2023 | Sowell Joseph A III | SVP; Chief Development Officer | G | Common Stock | 29771 | $0.00 | 72,701.0000 | 294,666,000 | 69.35% | 0.01% |
| Nov. 14, 2023 | Sowell Joseph A III | SVP; Chief Development Officer | G | Common Stock | 29771 | $0.00 | 72,701.0000 | 294,666,000 | 29.05% | 0.01% |
| Nov. 10, 2023 | Sowell Joseph A III | SVP; Chief Development Officer | G | Common Stock | 29771 | $0.00 | 72,701.0000 | 294,666,000 | 69.35% | 0.01% |
| Nov. 10, 2023 | Sowell Joseph A III | SVP; Chief Development Officer | G | Common Stock | 29771 | $0.00 | 72,701.0000 | 294,666,000 | 29.05% | 0.01% |
| Nov. 10, 2023 | Billington Phillip G | SVP-Internal Audit Services | M | Stock Appreciation Right | 5525 | $0.00 | 0.0000 | 294,666,000 | 100.00% | 0.00% |
| Nov. 10, 2023 | Billington Phillip G | SVP-Internal Audit Services | M | Stock Appreciation Right | 6500 | $0.00 | 0.0000 | 294,666,000 | 100.00% | 0.00% |
| Nov. 10, 2023 | Billington Phillip G | SVP-Internal Audit Services | F | Common Stock | 6237 | $232.82 | 49,860.4544 | 294,666,000 | 11.12% | 0.00% |
| Aug. 14, 2023 | RUTHERFORD BILL B | CFO and EVP | G | Common Stock | 40500 | $0.00 | 165,009.0000 | 294,666,000 | 19.71% | 0.01% |
| Aug. 14, 2023 | RUTHERFORD BILL B | CFO and EVP | G | Common Stock | 40500 | $0.00 | 115,509.0000 | 294,666,000 | 53.99% | 0.01% |
| Aug. 14, 2023 | RUTHERFORD BILL B | CFO and EVP | G | Common Stock | 49500 | $0.00 | 165,009.0000 | 294,666,000 | 23.08% | 0.02% |
| Aug. 14, 2023 | Torres Kathryn A. | SVP-Payer Contracting & Align. | S | Common Stock | 5204 | $269.12 | 19,760.0000 | 294,666,000 | 20.85% | 0.00% |
| Aug. 14, 2023 | RUTHERFORD BILL B | CFO and EVP | G | Common Stock | 49500 | $0.00 | 165,009.0000 | 294,666,000 | 42.85% | 0.02% |
| Aug. 11, 2023 | Cohen Jeffrey E. | SVP-Government Relations | S | Common Stock | 1500 | $270.00 | 4,414.0000 | 294,666,000 | 25.36% | 0.00% |
| Aug. 4, 2023 | Marks Mike A | SVP-Finance | G | Common Stock | 205 | $0.00 | 67,535.0000 | 294,666,000 | 0.30% | 0.00% |
| Aug. 3, 2023 | Whalen Kathleen M | SVP & Chief Ethics Officer | S | Common Stock | 2916 | $270.00 | 10,250.0000 | 294,666,000 | 22.15% | 0.00% |
| Aug. 3, 2023 | Marks Mike A | SVP-Finance | G | Common Stock | 8343 | $0.00 | 67,740.0000 | 294,666,000 | 10.97% | 0.00% |
| Aug. 3, 2023 | Marks Mike A | SVP-Finance | G | Common Stock | 8343 | $0.00 | 67,535.0000 | 294,666,000 | 14.09% | 0.00% |
| Aug. 2, 2023 | RUTHERFORD BILL B | CFO and EVP | G | Common Stock | 49500 | $0.00 | 165,009.0000 | 294,666,000 | 42.85% | 0.02% |
| Aug. 2, 2023 | RUTHERFORD BILL B | CFO and EVP | G | Common Stock | 49500 | $0.00 | 165,009.0000 | 294,666,000 | 23.08% | 0.02% |
| Aug. 1, 2023 | Foster Jon M | EVP and COO | G | Common Stock | 6100 | $0.00 | 146,161.0000 | 294,666,000 | 4.01% | 0.00% |
| Aug. 1, 2023 | Foster Jon M | EVP and COO | G | Common Stock | 6100 | $0.00 | 140,811.0000 | 294,666,000 | 4.53% | 0.00% |
| Aug. 1, 2023 | Foster Jon M | EVP and COO | G | Common Stock | 5350 | $0.00 | 140,811.0000 | 294,666,000 | 3.66% | 0.00% |
| Aug. 1, 2023 | Foster Jon M | EVP and COO | G | Common Stock | 5350 | $0.00 | 140,811.0000 | 294,666,000 | 3.95% | 0.00% |
| May 12, 2023 | Hammett Richard A | Group President | G | Common Stock | 1100 | $0.00 | 13,762.0000 | 294,666,000 | 7.40% | 0.00% |
| May 4, 2023 | HAZEN SAMUEL N | CEO | G | Common Stock | 4647 | $0.00 | 1,277,107.0000 | 294,666,000 | 0.36% | 0.00% |
| May 4, 2023 | HAZEN SAMUEL N | CEO | G | Common Stock | 7864 | $0.00 | 1,281,754.0000 | 294,666,000 | 0.61% | 0.00% |
| May 4, 2023 | HAZEN SAMUEL N | CEO | G | Common Stock | 7864 | $0.00 | 1,277,107.0000 | 294,666,000 | 0.62% | 0.00% |
| May 4, 2023 | HAZEN SAMUEL N | CEO | G | Common Stock | 4647 | $0.00 | 1,277,107.0000 | 294,666,000 | 0.37% | 0.00% |
| May 1, 2023 | Akdamar Erol R | Group President | G | Common Stock | 42484 | $0.00 | 102,484.0000 | 294,666,000 | 70.81% | 0.01% |
| May 1, 2023 | Akdamar Erol R | Group President | G | Common Stock | 42484 | $0.00 | 102,484.0000 | 294,666,000 | 29.31% | 0.01% |
| April 28, 2023 | Akdamar Erol R | Group President | S | Common Stock | 3500 | $285.00 | 144,968.0000 | 294,666,000 | 2.36% | 0.00% |
| April 28, 2023 | Torres Kathryn A. | SVP-Payer Contracting & Align. | M | Stock Appreciation Right | 3509 | $0.00 | 4,771.0000 | 294,666,000 | 42.38% | 0.00% |
| April 28, 2023 | Cuffe Michael S. | EVP and Chief Clinical Officer | S | Common Stock | 12556 | $284.44 | 28,783.3569 | 294,666,000 | 30.37% | 0.00% |
| April 28, 2023 | Torres Kathryn A. | SVP-Payer Contracting & Align. | M | Stock Appreciation Right | 5335 | $0.00 | 0.0000 | 294,666,000 | 100.00% | 0.00% |
| April 28, 2023 | Torres Kathryn A. | SVP-Payer Contracting & Align. | F | Common Stock | 6123 | $287.33 | 24,964.0000 | 294,666,000 | 19.70% | 0.00% |
| April 28, 2023 | Torres Kathryn A. | SVP-Payer Contracting & Align. | M | Common Stock | 3509 | $145.24 | 31,087.0000 | 294,666,000 | 12.72% | 0.00% |
| April 28, 2023 | Torres Kathryn A. | SVP-Payer Contracting & Align. | M | Common Stock | 5335 | $139.06 | 27,578.0000 | 294,666,000 | 23.99% | 0.00% |
| April 24, 2023 | Smith Andrea B | Director | A | Common Stock | 663 | $0.00 | 2,984.0000 | 294,666,000 | 28.57% | 0.00% |
| April 24, 2023 | FRIST THOMAS F III | Director | A | Common Stock, par value $0.01 per share | 1396 | $0.00 | 43,651,241.3079 | 294,666,000 | 0.00% | 0.00% |
| April 24, 2023 | Frist William R | Director | A | Common Stock, par value $0.01 per share | 1047 | $0.00 | 51,431,535.9593 | 294,666,000 | 0.00% | 0.00% |
| April 24, 2023 | DEPARLE NANCY ANN | Director | A | Common Stock | 663 | $0.00 | 20,146.0000 | 294,666,000 | 3.40% | 0.00% |
| April 24, 2023 | Dennis Robert J | Director | A | Common Stock | 1047 | $0.00 | 24,612.0000 | 294,666,000 | 4.44% | 0.00% |
| April 24, 2023 | Torres Kathryn A. | SVP-Payer Contracting & Align. | S | Common Stock | 4473 | $288.38 | 22,243.0000 | 294,666,000 | 16.74% | 0.00% |
| April 24, 2023 | Cuffe Michael S. | EVP and Chief Clinical Officer | M | Common Stock | 32020 | $101.16 | 60,803.3569 | 294,666,000 | 111.24% | 0.01% |
| April 24, 2023 | Cuffe Michael S. | EVP and Chief Clinical Officer | F | Common Stock | 19464 | $286.25 | 41,339.3569 | 294,666,000 | 32.01% | 0.01% |
| April 24, 2023 | Cuffe Michael S. | EVP and Chief Clinical Officer | M | Stock Appreciation Right | 32020 | $0.00 | 0.0000 | 294,666,000 | 100.00% | 0.01% |
| April 24, 2023 | CROFTON MEG | Director | A | Common Stock | 663 | $0.00 | 5,721.0000 | 294,666,000 | 13.11% | 0.00% |
| April 24, 2023 | MICHELSON MICHAEL W | Director | A | Common Stock | 1187 | $0.00 | 9,387.0000 | 294,666,000 | 14.48% | 0.00% |
| April 24, 2023 | Riley Wayne Joseph | Director | A | Common Stock | 663 | $0.00 | 13,265.0000 | 294,666,000 | 5.26% | 0.00% |
| April 24, 2023 | Johnston Hugh F | Director | A | Common Stock | 663 | $0.00 | 2,030.0000 | 294,666,000 | 48.50% | 0.00% |
| April 12, 2023 | Paslick P. Martin | SVP and CIO | F | Common Stock | 3653 | $272.38 | 154,329.0000 | 294,666,000 | 2.31% | 0.00% |
| April 12, 2023 | Paslick P. Martin | SVP and CIO | M | Common Stock | 6340 | $81.96 | 157,982.0000 | 294,666,000 | 4.18% | 0.00% |
| April 12, 2023 | Paslick P. Martin | SVP and CIO | M | Stock Appreciation Right | 6340 | $0.00 | 0.0000 | 294,666,000 | 100.00% | 0.00% |
| April 14, 2023 | Paslick P. Martin | SVP and CIO | S | Common Stock | 2687 | $275.00 | 151,642.0000 | 294,666,000 | 1.74% | 0.00% |
| April 10, 2023 | Paslick P. Martin | SVP and CIO | S | Common Stock | 2539 | $270.00 | 151,642.0000 | 294,666,000 | 1.65% | 0.00% |
| April 5, 2023 | Paslick P. Martin | SVP and CIO | F | Common Stock | 3461 | $271.31 | 154,181.0000 | 294,666,000 | 2.20% | 0.00% |
| April 4, 2023 | Paslick P. Martin | SVP and CIO | S | Common Stock | 3034 | $265.00 | 151,642.0000 | 294,666,000 | 1.96% | 0.00% |
| April 5, 2023 | Paslick P. Martin | SVP and CIO | M | Stock Appreciation Right | 6000 | $0.00 | 6,340.0000 | 294,666,000 | 48.62% | 0.00% |
| April 5, 2023 | Paslick P. Martin | SVP and CIO | M | Common Stock | 6000 | $81.96 | 157,642.0000 | 294,666,000 | 3.96% | 0.00% |
| Feb. 17, 2023 | Berres Jennifer | SVP & Chief Human Res. Officer | A | Common Stock | 7600 | $0.00 | 14,992.0000 | 294,666,000 | 102.81% | 0.00% |
| Feb. 17, 2023 | Wyatt Christopher F. | SVP & Controller | A | Common Stock | 6080 | $0.00 | 38,472.0000 | 294,666,000 | 18.77% | 0.00% |
| Feb. 17, 2023 | Wyatt Christopher F. | SVP & Controller | F | Common Stock | 2393 | $262.84 | 36,079.0000 | 294,666,000 | 6.22% | 0.00% |
| Feb. 17, 2023 | Whalen Kathleen M | SVP & Chief Ethics Officer | S | Common Stock | 1734 | $263.61 | 9,962.0000 | 294,666,000 | 14.83% | 0.00% |
| Feb. 17, 2023 | Whalen Kathleen M | SVP & Chief Ethics Officer | A | Common Stock | 4560 | $0.00 | 14,522.0000 | 294,666,000 | 45.77% | 0.00% |
| Feb. 17, 2023 | Whalen Kathleen M | SVP & Chief Ethics Officer | F | Common Stock | 1356 | $262.84 | 13,166.0000 | 294,666,000 | 9.34% | 0.00% |
| Feb. 17, 2023 | Torres Kathryn A. | SVP-Payer Contracting & Align. | A | Common Stock | 6080 | $0.00 | 28,560.0000 | 294,666,000 | 27.05% | 0.00% |
| Feb. 17, 2023 | Torres Kathryn A. | SVP-Payer Contracting & Align. | F | Common Stock | 1844 | $262.84 | 26,716.0000 | 294,666,000 | 6.46% | 0.00% |
| Feb. 17, 2023 | Sowell Joseph A III | SVP; Chief Development Officer | A | Common Stock | 7600 | $0.00 | 45,371.0000 | 294,666,000 | 20.12% | 0.00% |
| Feb. 17, 2023 | Sowell Joseph A III | SVP; Chief Development Officer | F | Common Stock | 2441 | $262.84 | 42,930.0000 | 294,666,000 | 5.38% | 0.00% |
| Feb. 17, 2023 | RUTHERFORD BILL B | CFO and EVP | A | Common Stock | 24300 | $0.00 | 174,572.0000 | 294,666,000 | 16.17% | 0.01% |
| Feb. 17, 2023 | RUTHERFORD BILL B | CFO and EVP | F | Common Stock | 9563 | $262.84 | 165,009.0000 | 294,666,000 | 5.48% | 0.00% |
| Feb. 17, 2023 | Reiner Deborah M | SVP - Mktg. & Communications | A | Common Stock | 4560 | $0.00 | 4,560.0000 | 294,666,000 | 9999.99% | 0.00% |
| Feb. 17, 2023 | Reiner Deborah M | SVP - Mktg. & Communications | F | Common Stock | 1246 | $262.84 | 3,314.0000 | 294,666,000 | 27.32% | 0.00% |
| Feb. 17, 2023 | Paslick P. Martin | SVP and CIO | A | Common Stock | 9120 | $0.00 | 158,265.0000 | 294,666,000 | 6.11% | 0.00% |
| Feb. 17, 2023 | Paslick P. Martin | SVP and CIO | F | Common Stock | 3589 | $262.84 | 154,676.0000 | 294,666,000 | 2.27% | 0.00% |
| Feb. 17, 2023 | Mosier Sammie S | SVP & Chief Nurse Executive | A | Common Stock | 1120 | $0.00 | 8,063.0000 | 294,666,000 | 16.13% | 0.00% |
| Feb. 17, 2023 | Mosier Sammie S | SVP & Chief Nurse Executive | F | Common Stock | 273 | $262.84 | 7,790.0000 | 294,666,000 | 3.39% | 0.00% |
| Feb. 17, 2023 | McManus Timothy M | Group President | A | Common Stock | 7600 | $0.00 | 21,587.4141 | 294,666,000 | 54.33% | 0.00% |
| Feb. 17, 2023 | McManus Timothy M | Group President | F | Common Stock | 2438 | $262.84 | 19,149.4141 | 294,666,000 | 11.29% | 0.00% |
| Feb. 17, 2023 | Marks Mike A | SVP-Finance | A | Common Stock | 6080 | $0.00 | 69,587.0000 | 294,666,000 | 9.57% | 0.00% |
| Feb. 17, 2023 | Marks Mike A | SVP-Finance | F | Common Stock | 1847 | $262.84 | 67,740.0000 | 294,666,000 | 2.65% | 0.00% |
| Feb. 17, 2023 | HAZEN SAMUEL N | CEO | A | Common Stock | 94880 | $0.00 | 1,313,877.0000 | 294,666,000 | 7.78% | 0.03% |
| Feb. 17, 2023 | HAZEN SAMUEL N | CEO | F | Common Stock | 36770 | $262.84 | 1,277,107.0000 | 294,666,000 | 2.80% | 0.01% |
| Feb. 17, 2023 | Hammett Richard A | Group President | A | Common Stock | 2060 | $0.00 | 10,656.0000 | 294,666,000 | 23.96% | 0.00% |
| Feb. 17, 2023 | Hammett Richard A | Group President | A | Common Stock | 7620 | $0.00 | 18,276.0000 | 294,666,000 | 71.51% | 0.00% |
| Feb. 17, 2023 | Hammett Richard A | Group President | F | Common Stock | 3414 | $262.84 | 14,862.0000 | 294,666,000 | 18.68% | 0.00% |
| Feb. 17, 2023 | Foster Jon M | EVP and COO | A | Common Stock | 19740 | $0.00 | 148,579.0000 | 294,666,000 | 15.32% | 0.01% |
| Feb. 17, 2023 | Foster Jon M | EVP and COO | F | Common Stock | 7768 | $262.84 | 140,811.0000 | 294,666,000 | 5.23% | 0.00% |
| Feb. 17, 2023 | Cuffe Michael S. | EVP and Chief Clinical Officer | A | Common Stock | 12160 | $0.00 | 32,982.5543 | 294,666,000 | 58.40% | 0.00% |
| Feb. 17, 2023 | Cuffe Michael S. | EVP and Chief Clinical Officer | F | Common Stock | 4232 | $262.84 | 28,750.5543 | 294,666,000 | 12.83% | 0.00% |
| Feb. 17, 2023 | Cohen Jeffrey E. | SVP-Government Relations | A | Common Stock | 4560 | $0.00 | 7,566.0000 | 294,666,000 | 151.70% | 0.00% |
| Feb. 17, 2023 | Cohen Jeffrey E. | SVP-Government Relations | F | Common Stock | 1652 | $262.84 | 5,914.0000 | 294,666,000 | 21.83% | 0.00% |
| Feb. 17, 2023 | Billington Phillip G | SVP-Internal Audit Services | A | Common Stock | 4560 | $0.00 | 45,212.1056 | 294,666,000 | 11.22% | 0.00% |
| Feb. 17, 2023 | Billington Phillip G | SVP-Internal Audit Services | F | Common Stock | 1247 | $262.84 | 43,965.1056 | 294,666,000 | 2.76% | 0.00% |
| Feb. 17, 2023 | Berres Jennifer | SVP & Chief Human Res. Officer | F | Common Stock | 2441 | $262.84 | 12,551.0000 | 294,666,000 | 16.28% | 0.00% |
| Feb. 17, 2023 | Akdamar Erol R | Group President | A | Common Stock | 9300 | $0.00 | 109,094.0000 | 294,666,000 | 9.32% | 0.00% |
| Feb. 17, 2023 | Akdamar Erol R | Group President | F | Common Stock | 3110 | $262.84 | 105,984.0000 | 294,666,000 | 2.85% | 0.00% |
| Feb. 16, 2023 | Torres Kathryn A. | SVP-Payer Contracting & Align. | M | Stock Appreciation Right | 4575 | $0.00 | 0.0000 | 294,666,000 | 100.00% | 0.00% |
| Feb. 16, 2023 | Torres Kathryn A. | SVP-Payer Contracting & Align. | F | Common Stock | 2467 | $263.15 | 22,480.0000 | 294,666,000 | 9.89% | 0.00% |
| Feb. 16, 2023 | Torres Kathryn A. | SVP-Payer Contracting & Align. | M | Common Stock | 4575 | $101.16 | 24,947.0000 | 294,666,000 | 22.46% | 0.00% |
| Feb. 7, 2023 | Berres Jennifer | SVP & Chief Human Res. Officer | S | Common Stock | 4000 | $255.23 | 7,392.0000 | 294,666,000 | 35.11% | 0.00% |
| Feb. 3, 2023 | Mosier Sammie S | SVP & Chief Nurse Executive | M | Common Stock | 138 | $0.00 | 6,984.0000 | 294,666,000 | 2.02% | 0.00% |
| Feb. 3, 2023 | Mosier Sammie S | SVP & Chief Nurse Executive | F | Common Stock | 41 | $258.08 | 6,943.0000 | 294,666,000 | 0.59% | 0.00% |
| Feb. 3, 2023 | Mosier Sammie S | SVP & Chief Nurse Executive | M | Restricted Stock Units | 138 | $0.00 | 275.0000 | 294,666,000 | 33.41% | 0.00% |
| Feb. 3, 2023 | Reiner Deborah M | SVP - Mktg. & Communications | S | Common Stock | 7941 | $257.61 | 0.0000 | 294,666,000 | 100.00% | 0.00% |
| Feb. 3, 2023 | HAZEN SAMUEL N | CEO | M | Common Stock | 59000 | $68.96 | 1,251,205.0000 | 294,666,000 | 4.95% | 0.02% |
| Feb. 3, 2023 | HAZEN SAMUEL N | CEO | F | Common Stock | 32208 | $258.08 | 1,218,997.0000 | 294,666,000 | 2.57% | 0.01% |
| Feb. 3, 2023 | HAZEN SAMUEL N | CEO | M | Stock Appreciation Right | 59000 | $0.00 | 0.0000 | 294,666,000 | 100.00% | 0.02% |
| Feb. 3, 2023 | Akdamar Erol R | Group President | M | Stock Appreciation Right | 9000 | $0.00 | 0.0000 | 294,666,000 | 100.00% | 0.00% |
| Feb. 2, 2023 | Akdamar Erol R | Group President | S | Common Stock | 3000 | $258.63 | 94,726.0000 | 294,666,000 | 3.07% | 0.00% |
| Feb. 3, 2023 | Akdamar Erol R | Group President | M | Common Stock | 9000 | $45.30 | 103,726.0000 | 294,666,000 | 9.50% | 0.00% |
| Feb. 3, 2023 | Akdamar Erol R | Group President | F | Common Stock | 3932 | $258.08 | 99,794.0000 | 294,666,000 | 3.79% | 0.00% |
| Feb. 1, 2023 | RUTHERFORD BILL B | CFO and EVP | F | Common Stock | 34895 | $261.46 | 180,272.0000 | 294,666,000 | 16.22% | 0.01% |
| Feb. 1, 2023 | RUTHERFORD BILL B | CFO and EVP | M | Common Stock | 27000 | $69.58 | 215,167.0000 | 294,666,000 | 14.35% | 0.01% |
| Feb. 1, 2023 | RUTHERFORD BILL B | CFO and EVP | M | Common Stock | 37000 | $68.96 | 188,167.0000 | 294,666,000 | 24.48% | 0.01% |
| Feb. 1, 2023 | RUTHERFORD BILL B | CFO and EVP | M | Stock Appreciation Right | 27000 | $0.00 | 19,100.0000 | 294,666,000 | 58.57% | 0.01% |
| Feb. 1, 2023 | RUTHERFORD BILL B | CFO and EVP | M | Stock Appreciation Right | 37000 | $0.00 | 0.0000 | 294,666,000 | 100.00% | 0.01% |
| Feb. 3, 2023 | RUTHERFORD BILL B | CFO and EVP | S | Common Stock | 30000 | $258.19 | 150,272.0000 | 294,666,000 | 16.64% | 0.01% |
| Jan. 30, 2023 | Mosier Sammie S | SVP & Chief Nurse Executive | A | Stock Appreciation Right | 5052 | $0.00 | 5,052.0000 | 294,666,000 | 9999.99% | 0.00% |
| Jan. 30, 2023 | Paslick P. Martin | SVP and CIO | A | Stock Appreciation Right | 9472 | $0.00 | 9,472.0000 | 294,666,000 | 9999.99% | 0.00% |
| Feb. 1, 2023 | Paslick P. Martin | SVP and CIO | S | Common Stock | 1000 | $256.95 | 149,145.0000 | 294,666,000 | 0.67% | 0.00% |
| Jan. 30, 2023 | Reiner Deborah M | SVP - Mktg. & Communications | A | Stock Appreciation Right | 5052 | $0.00 | 5,052.0000 | 294,666,000 | 9999.99% | 0.00% |
| Jan. 30, 2023 | RUTHERFORD BILL B | CFO and EVP | A | Stock Appreciation Right | 23680 | $0.00 | 23,680.0000 | 294,666,000 | 9999.99% | 0.01% |
| Nov. 2, 2022 | RUTHERFORD BILL B | CFO and EVP | G | Common Stock | 450 | $0.00 | 151,167.0000 | 0 | 0.30% | 0.00% |
| May 10, 2022 | RUTHERFORD BILL B | CFO and EVP | G | Common Stock | 18640 | $0.00 | 151,167.0000 | 0 | 14.07% | 0.00% |
| May 10, 2022 | RUTHERFORD BILL B | CFO and EVP | G | Common Stock | 18640 | $0.00 | 151,167.0000 | 0 | 10.98% | 0.00% |
| Jan. 30, 2023 | Sowell Joseph A III | SVP; Chief Development Officer | A | Stock Appreciation Right | 6315 | $0.00 | 6,315.0000 | 294,666,000 | 9999.99% | 0.00% |
| Jan. 30, 2023 | Torres Kathryn A. | SVP-Payer Contracting & Align. | A | Stock Appreciation Right | 5052 | $0.00 | 5,052.0000 | 294,666,000 | 9999.99% | 0.00% |
| Jan. 31, 2023 | Whalen Kathleen M | SVP & Chief Ethics Officer | M | Stock Appreciation Right | 1250 | $0.00 | 2,510.0000 | 294,666,000 | 33.24% | 0.00% |
| Jan. 30, 2023 | Berres Jennifer | SVP & Chief Human Res. Officer | A | Stock Appreciation Right | 10735 | $0.00 | 10,735.0000 | 294,666,000 | 9999.99% | 0.00% |
| Feb. 1, 2023 | Whalen Kathleen M | SVP & Chief Ethics Officer | F | Common Stock | 586 | $255.07 | 11,696.0000 | 294,666,000 | 4.77% | 0.00% |
| Jan. 31, 2023 | Whalen Kathleen M | SVP & Chief Ethics Officer | M | Common Stock | 1250 | $69.58 | 12,282.0000 | 294,666,000 | 11.33% | 0.00% |
| Jan. 31, 2023 | Whalen Kathleen M | SVP & Chief Ethics Officer | G | Common Stock | 341 | $0.00 | 11,032.0000 | 294,666,000 | 3.00% | 0.00% |
| Jan. 30, 2023 | Wyatt Christopher F. | SVP & Controller | A | Stock Appreciation Right | 5052 | $0.00 | 5,052.0000 | 294,666,000 | 9999.99% | 0.00% |
| Jan. 30, 2023 | Wyatt Christopher F. | SVP & Controller | M | Stock Appreciation Right | 12000 | $0.00 | 2,680.0000 | 294,666,000 | 81.74% | 0.00% |
| Feb. 1, 2023 | Wyatt Christopher F. | SVP & Controller | S | Common Stock | 4900 | $253.30 | 32,392.0000 | 294,666,000 | 13.14% | 0.00% |
| Jan. 31, 2023 | Wyatt Christopher F. | SVP & Controller | G | Common Stock | 379 | $0.00 | 37,292.0000 | 294,666,000 | 1.01% | 0.00% |
| Jan. 30, 2023 | Wyatt Christopher F. | SVP & Controller | F | Common Stock | 6513 | $253.30 | 37,671.0000 | 294,666,000 | 14.74% | 0.00% |
| Jan. 30, 2023 | Wyatt Christopher F. | SVP & Controller | M | Common Stock | 12000 | $81.96 | 44,184.0000 | 294,666,000 | 37.29% | 0.00% |
| Jan. 30, 2023 | Whalen Kathleen M | SVP & Chief Ethics Officer | A | Stock Appreciation Right | 3789 | $0.00 | 3,789.0000 | 294,666,000 | 9999.99% | 0.00% |
| Jan. 30, 2023 | Akdamar Erol R | Group President | A | Stock Appreciation Right | 17051 | $0.00 | 17,051.0000 | 294,666,000 | 9999.99% | 0.01% |
| Jan. 30, 2023 | Billington Phillip G | SVP-Internal Audit Services | A | Stock Appreciation Right | 3789 | $0.00 | 3,789.0000 | 294,666,000 | 9999.99% | 0.00% |
| Jan. 30, 2023 | Cohen Jeffrey E. | SVP-Government Relations | A | Stock Appreciation Right | 3789 | $0.00 | 3,789.0000 | 294,666,000 | 9999.99% | 0.00% |
| Jan. 30, 2023 | Cuffe Michael S. | EVP and Chief Clinical Officer | A | Stock Appreciation Right | 14524 | $0.00 | 14,524.0000 | 294,666,000 | 9999.99% | 0.00% |
| Feb. 1, 2023 | Cuffe Michael S. | EVP and Chief Clinical Officer | S | Common Stock | 4000 | $257.11 | 20,822.5543 | 294,666,000 | 16.11% | 0.00% |
| Oct. 31, 2022 | Cuffe Michael S. | EVP and Chief Clinical Officer | G | Common Stock | 450 | $0.00 | 24,822.5543 | 0 | 1.78% | 0.00% |
| Jan. 30, 2023 | Foster Jon M | EVP and COO | A | Stock Appreciation Right | 23680 | $0.00 | 23,680.0000 | 294,666,000 | 9999.99% | 0.01% |
| Jan. 30, 2023 | Foster Jon M | EVP and COO | M | Stock Appreciation Right | 11955 | $0.00 | 11,955.0000 | 294,666,000 | 50.00% | 0.00% |
| Jan. 30, 2023 | Foster Jon M | EVP and COO | M | Stock Appreciation Right | 24000 | $0.00 | 0.0000 | 294,666,000 | 100.00% | 0.01% |
| Feb. 1, 2023 | Foster Jon M | EVP and COO | S | Common Stock | 16424 | $251.98 | 128,839.0000 | 294,666,000 | 11.31% | 0.01% |
| Jan. 30, 2023 | Foster Jon M | EVP and COO | F | Common Stock | 19531 | $253.30 | 145,263.0000 | 294,666,000 | 11.85% | 0.01% |
| Jan. 30, 2023 | Foster Jon M | EVP and COO | M | Common Stock | 11955 | $69.58 | 164,794.0000 | 294,666,000 | 7.82% | 0.00% |
| Jan. 30, 2023 | Foster Jon M | EVP and COO | M | Common Stock | 24000 | $68.96 | 152,839.0000 | 294,666,000 | 18.63% | 0.01% |
| Jan. 30, 2023 | Hammett Richard A | Group President | A | Stock Appreciation Right | 17051 | $0.00 | 17,051.0000 | 294,666,000 | 9999.99% | 0.01% |
| Jan. 30, 2023 | HAZEN SAMUEL N | CEO | A | Stock Appreciation Right | 82880 | $0.00 | 82,880.0000 | 294,666,000 | 9999.99% | 0.03% |
| Jan. 30, 2023 | Marks Mike A | SVP-Finance | A | Stock Appreciation Right | 7578 | $0.00 | 7,578.0000 | 294,666,000 | 9999.99% | 0.00% |
| Jan. 30, 2023 | McAlevey Michael R | SVP & Chief Legal Officer | A | Stock Appreciation Right | 12630 | $0.00 | 12,630.0000 | 294,666,000 | 9999.99% | 0.00% |
| Jan. 30, 2023 | McManus Timothy M | Group President | A | Stock Appreciation Right | 17051 | $0.00 | 17,051.0000 | 294,666,000 | 9999.99% | 0.01% |
| Jan. 30, 2023 | McManus Timothy M | Group President | S | Common Stock | 100 | $254.60 | 13,987.4141 | 294,666,000 | 0.71% | 0.00% |
| Jan. 30, 2023 | McManus Timothy M | Group President | S | Common Stock | 7800 | $254.05 | 14,087.4141 | 294,666,000 | 35.64% | 0.00% |
| Jan. 29, 2023 | Mosier Sammie S | SVP & Chief Nurse Executive | M | Common Stock | 322 | $0.00 | 6,743.0000 | 294,666,000 | 5.01% | 0.00% |
| Jan. 30, 2023 | Mosier Sammie S | SVP & Chief Nurse Executive | F | Common Stock | 74 | $253.30 | 6,846.0000 | 294,666,000 | 1.07% | 0.00% |
| Jan. 30, 2023 | Mosier Sammie S | SVP & Chief Nurse Executive | M | Common Stock | 273 | $0.00 | 6,920.0000 | 294,666,000 | 4.11% | 0.00% |
| Jan. 29, 2023 | Mosier Sammie S | SVP & Chief Nurse Executive | F | Common Stock | 96 | $254.77 | 6,647.0000 | 294,666,000 | 1.42% | 0.00% |
| Jan. 30, 2023 | Hammett Richard A | Group President | M | Restricted Stock Units | 598 | $0.00 | 0.0000 | 294,666,000 | 100.00% | 0.00% |
| Jan. 29, 2023 | Hammett Richard A | Group President | M | Restricted Stock Units | 600 | $0.00 | 600.0000 | 294,666,000 | 50.00% | 0.00% |
| Jan. 30, 2023 | Hammett Richard A | Group President | F | Common Stock | 146 | $253.30 | 8,596.0000 | 294,666,000 | 1.67% | 0.00% |
| Jan. 30, 2023 | Hammett Richard A | Group President | M | Common Stock | 598 | $0.00 | 8,742.0000 | 294,666,000 | 7.34% | 0.00% |
| Jan. 29, 2023 | Hammett Richard A | Group President | F | Common Stock | 165 | $254.77 | 8,144.0000 | 294,666,000 | 1.99% | 0.00% |
| Jan. 29, 2023 | Hammett Richard A | Group President | M | Common Stock | 600 | $0.00 | 8,309.0000 | 294,666,000 | 7.78% | 0.00% |
| Jan. 28, 2023 | McAlevey Michael R | SVP & Chief Legal Officer | M | Restricted Stock Units | 1940 | $0.00 | 1,940.0000 | 294,666,000 | 50.00% | 0.00% |
| Jan. 28, 2023 | McAlevey Michael R | SVP & Chief Legal Officer | F | Common Stock | 489 | $254.77 | 2,587.0000 | 294,666,000 | 15.90% | 0.00% |
| Jan. 28, 2023 | McAlevey Michael R | SVP & Chief Legal Officer | M | Common Stock | 1940 | $0.00 | 3,076.0000 | 294,666,000 | 170.77% | 0.00% |
| Jan. 30, 2023 | Mosier Sammie S | SVP & Chief Nurse Executive | M | Restricted Stock Units | 273 | $0.00 | 0.0000 | 294,666,000 | 100.00% | 0.00% |
| Jan. 29, 2023 | Mosier Sammie S | SVP & Chief Nurse Executive | M | Restricted Stock Units | 322 | $0.00 | 323.0000 | 294,666,000 | 49.92% | 0.00% |
| Jan. 23, 2023 | Paslick P. Martin | SVP and CIO | F | Common Stock | 2966 | $263.81 | 150,145.0000 | 294,666,000 | 1.94% | 0.00% |
| Jan. 23, 2023 | Paslick P. Martin | SVP and CIO | M | Common Stock | 6000 | $81.96 | 153,111.0000 | 294,666,000 | 4.08% | 0.00% |
| Jan. 23, 2023 | Paslick P. Martin | SVP and CIO | M | Stock Appreciation Right | 6000 | $0.00 | 12,340.0000 | 294,666,000 | 32.72% | 0.00% |